The Longevity Digest 05/12 - 05/18
I'm cutting through the noise in longevity and anti-aging podcasts so you don't have to.
Welcome to The Longevity Digest.
The field moves fast. Too fast for most of us to track every breakthrough, every protocol update, every researcher’s latest findings. That’s where this comes in.
I’ve curated specific shows that consistently deliver evidence-based insights you can actually use. Think less fluff, more substance. The kind of information that changes how you practice or how you live.
Got a podcast that’s been delivering gold? Send it my way. I’m always hunting for voices that push the field forward.
This Newsletter Is Sponsored By Casa de Sante.
Dr Onyx MD PhD’s Insights on this week’s episodes
The N-of-1 Revolution: From Population Medicine to Your Internal Pharmacy
The most powerful signal across this cycle’s episodes is not a single molecule or protocol — it’s a fundamental shift in how we conceptualize care. As discussed on The Human Upgrade Episode 1425 (”Why Are Hackers Microdosing ‘Sex Drugs’ Now?”), precision longevity demands moving beyond population-averaged epidemiology toward a multi-omic, N-of-1 model: genomics cascading through transcriptomics, proteomics, metabolomics, and ultimately the exposome — the full environmental fingerprint of an individual’s biology. The architecture of this approach is already in motion at the policy level: CDC Director Jim O’Neill, speaking on The Human Upgrade Episode 1449, described a $144M ARPA-H initiative to identify and FDA-validate causal biomarkers of aging — not correlative ones — to create credible surrogate endpoints for longevity therapies. That distinction matters enormously. A surrogate endpoint you can trust changes clinical trial design, drug approval pathways, and ultimately how fast science reaches patients.
Layered on top of that is the emerging pharmacology of biological age itself. Dr. Kara Fitzgerald, on The Human Upgrade Episode 1461 (”Eat These Foods + Spices for 8 Weeks To Get 3 Years Younger”), reported that an 8-week randomized dietary and lifestyle program — dense in methyl-donor foods and polyphenol-rich herbs and spices — reversed epigenetic age by over three years on the Horvath clock, with subsequent analysis pointing to the nutritional components as the primary drivers. This is the internal pharmacy in action: curcumin, EGCG, rosemary, and urolithin A not merely as supplements but as epigenetic reprogramming agents. And Fitzgerald’s emerging work points even further upstream, toward polycomb repressive complex 2 (PRC2) and the Yamanaka factor biology that governs whether your cells remember being young. The dietary lever, once dismissed as soft science, is now sitting at the leading edge of rejuvenation biology.
Actionable pivot: In clinical practice, this means biomarker architecture matters more than any single intervention. The advanced panel now includes not just ApoB, Lp(a), and homocysteine, but MMP-9, TGF-β1, C4a, and epigenetic age clocks — markers that collectively reveal where a patient’s aging biology is accelerating and where a targeted intervention will land hardest.
This Newsletter Is Sponsored By Casa de Sante.
For anyone on GLP-1 medications like Ozempic or Wegovy, Low FODMAP nutrition is non-negotiable. These medications can slow digestion and trigger bloating or nausea, so choosing gut-friendly products helps you stay comfortable while protecting muscle and metabolism. Physician-formulated by Dr Onyx MD PhD Certified in Obesity Management, this Low FODMAP lineup supports nutrient absorption, muscle defense, and overall digestive balance:
Premium Protein Powder (Vegan Vanilla, Whey Vanilla, or Whey Chocolate) – helps preserve lean muscle during weight loss
FODMAP Digestive Enzymes – improves absorption and reduces GI side effects
Advanced Probiotic + Prebiotic Synbiotic Formula – supports a balanced gut microbiome
Essential Vitamin & Mineral Complex – replenishes nutrients often depleted during rapid weight loss
Gentle Colon Cleanse + Probiotic Support – aids regular elimination without irritation
All formulas are low FODMAP, non-GMO, and third-party tested—the ideal foundation for GLP-1 users focused on digestive comfort, metabolic health, and muscle preservation.
Because hormones and skin health are deeply connected, Dr Onyx MD PhD science-backed skincare supports barrier repair, hydration, and inflammation balance for healthy, resilient skin—especially during menopause or while using GLP-1 medications, when collagen loss and dryness can accelerate:
HydraLift Collagen Complex – firms and smooths for youthful elasticity
Antioxidant C+E Ferulic Radiance Serum – brightens and defends against oxidative stress
Needle-Free Wrinkle Smoother – softens fine lines without irritation
Ultra Retinol 10x + Bakuchiol Serum – boosts cell turnover with gentle plant retinol
Advanced Retinol Eye Repair – targets puffiness and under-eye wrinkles
Cellular Repair Growth Factor Peptides Serum – rejuvenates and supports skin repair
Advanced Neck Lift Firming Complex – improves tone and texture along the jawline and neck
Even Tone Brightening Cream – evens discoloration for radiant, balanced skin
Dr Onyx Adegbola MD PhD
Track Smarter. Eat Better. Thrive. Download the GLP1 Support App at https://casadesante.com/pages/app-glp-1-support-by-dr-onyx-md-phd
The Mitochondria Are the Message: Energy, Oxygen, and the Cellular Doom Loop
If precision medicine is the strategic framework, mitochondrial biology is the tactical battlefield. Multiple episodes this cycle converged on the same uncomfortable insight: tissue-level hypoxia persists even when pulse oximetry reads normal, because the problem is not oxygen in the bloodstream — it’s oxygen failing to reach cells due to endothelial swelling, reduced red blood cell deformability, and microcirculatory dysfunction. As Brad Pitzele explained on The Human Upgrade Episode 1458 (”The Strangest Thing I Do Every Morning”), this creates a “pseudo-hypoxia” doom loop: impaired mitochondria shift to low-yield anaerobic metabolism, generating more inflammatory byproducts that further damage endothelium, which restricts oxygen delivery even further.
The proposed solution is a sequenced two-step protocol. Exercise with Oxygen Therapy (EWOT) — delivering approximately 93% oxygen during 10–15 minutes of moderate exercise — uses exercise-induced vasodilation and pressure gradients to physically drive oxygen past swollen endothelial cells and into hypoxic tissues. Stacking red/near-infrared photobiomodulation (PBM) immediately afterward then capitalizes on that elevated oxygen availability by increasing mitochondrial demand via cytochrome c oxidase and amplifying nitric oxide-mediated vasodilation. The timing is deliberate and pharmacokinetically logical: supply first, then demand.
Physicist John Cramer, PhD, on Health Longevity Secrets (”The 91-Year-Old Physicist Betting His Body on Mitochondrial Transplant”), offered perhaps the most radical extension of this theme. His central hypothesis: aging is primarily an energy crisis driven by accumulating mtDNA replication errors — not free radical damage as the old theory held — with clonal expansion of defective mitochondria accelerating around age 65. Many downstream hallmarks of aging, on this view, are simply the body triaging energy to keep the heart and brain running while everything else degrades. His early right-to-try experience with platelet-derived mitochondrial transplantation (”mitelets”) represents a frontier that most clinicians are not yet tracking — but should be. The concept is mechanistically coherent, the early safety signals are encouraging, and the clinical trial landscape is evolving fast.
Actionable pivot: For patients with persistent fatigue, post-viral syndrome, or cognitive fog despite normal standard labs, think endothelial and mitochondrial first. Consider pulse wave velocity as a vascular aging biomarker, investigate the EWOT-PBM stacking protocol for appropriate patients, and monitor the mitochondrial transplantation trial literature — particularly in acute cardiac ischemia and post-viral lung injury contexts.
The Social-Circadian Axis: Why Sleep Timing, Connection, and Awe Are Now Clinical Variables
The third convergent theme is less dramatic but arguably the most immediately actionable: a cluster of behavioral and environmental factors that are reshaping cardiovascular and psychiatric risk — and that most clinicians are still not routinely screening for.
Start with sleep timing. The Human Upgrade Episode 1467 (”Semen Switch, Chewing Gum, Creatine Cheat, Cancer Plants, and Bedtime Risk”) highlighted a Finnish accelerometer cohort showing that irregular bedtimes combined with short sleep duration roughly doubled the 10-year risk of major cardiovascular events. This is not about sleep duration — it’s about circadian regularity. The prescriptive implication is simple and costs nothing: counsel patients to maintain a consistent 90-minute bedtime window every night, including weekends.
The social dimension received equally rigorous treatment. Dr. David Anderson, in Huberman Lab’s “Essentials: The Biology of Aggression, Mating & Arousal,” delivered a finding that should reframe how clinicians assess irritability and anxiety: social isolation upregulates tachykinin 2 signaling across the brain, producing a druggable neurochemical state that amplifies aggression and fear — and that can be reversed in animal models with an NK3 receptor antagonist (osanetant) without sedation. Isolation is not a benign social condition; it is a biologically active one with measurable circuit-level consequences. Meanwhile, Dr. Nick Epley on Huberman Lab (”How to Overcome Social Anxiety”) provided the behavioral complement: people systematically overestimate social rejection, and graded real-world exposure — not simulation — is the mechanism that corrects those miscalibrated predictions and reduces anxiety. His “social prescription” is as evidence-based as any supplement protocol: one brief daily in-person or voice interaction, escalated weekly.
Perhaps the most underestimated clinical tool in this cycle came from Dr. Dacher Keltner on Huberman Lab (”Cultivating Awe & Emotional Connection in Daily Life”). Awe — the measurable neurological state induced by shifting perceptual focus from small to vast — demonstrably increases vagal tone (HRV), reduces inflammatory markers, lowers physical pain, and in an 8-week RCT of older adults, improved well-being and reduced bodily pain with a once-weekly 20–30 minute “awe walk.” For a field that relentlessly pursues molecular complexity, a walk in nature with deliberate attention to the horizon is a legitimate anti-inflammatory intervention. The mechanism links directly back to Section I: awe engages the same cholinergic anti-inflammatory pathway — α7nAChR/JAK-STAT/NF-κB — that vagal nerve stimulation targets pharmacologically. The brain, it turns out, does not always need a device to access its own internal pharmacy.
Actionable pivot: Add a social-circadian audit to your intake. Screen for bedtime variability, social isolation, and daily awe exposure with the same rigor applied to ApoB and blood pressure — because the evidence now supports treating all three as modifiable cardiovascular and neuropsychiatric risk factors.
This weeks episodes:
1. The Human Upgrade: Biohacking for Longevity & Performance
Why Are Hackers Microdosing “Sex Drugs” Now? : 1425
Published: 2026-03-03
URL: Listen Here
Summary
This episode advocates for precision medicine that integrates multi-omic data, autonomic modulation, and targeted therapeutics to optimize longevity. It highlights vagal nerve stimulation’s ability to downregulate the NLRP3 inflammasome, the need to individualize drugs and peptides, and the centrality of vascular tone/perfusion and mitochondrial function to healthy aging. Some claims are anecdotal and product-related; specific study details were not always provided in the discussion.
Key Takeaways
Precision medicine should move beyond one-size-fits-all epidemiology to N-of-1 care using multi-omics (genomics → transcriptomics → proteomics → metabolomics/exposome) to match the right intervention to the right person at the right time.
Vagal nerve stimulation engages the cholinergic anti-inflammatory pathway (α7nAChR/JAK–STAT/NF-κB) and can downregulate the NLRP3 inflammasome, a central driver of systemic inflammation and fibrosis; simple adjuncts like EGCG may also modulate NLRP3 activity.
Longevity pharmacology must be individualized: metformin is not universally beneficial (mitochondrial blunting/VO2 max concerns), rapamycin safety data are emerging (PEARL trial) but endpoints matter, and low-dose, pathway-targeted use of drugs and peptides (e.g., BPC-157, KPV, CJC-1295 with ipamorelin, PT-141) can have bioregulatory effects when used judiciously.
Vascular tone and perfusion are foundational to brain and sexual health; strategies include nitric oxide support, selective PDE5 inhibitor use (e.g., low-dose tadalafil in appropriate patients), and device-based approaches like acoustic shockwave therapy, which may promote neovascularization and lower MMP-9.
Actionable biomarkers beyond routine labs that inform aging biology include homocysteine, ApoB, Lp(a), TGF-β1, MMP-9, and C4a; pairing these with mitochondrial/energy-oriented interventions (IHHT, photobiomodulation, PEMF, HBOT) and exposome assessment can improve outcomes while AI can help sequence interventions efficiently.
Clinical Insight
Targeting autonomic balance and inflammatory set-points—specifically via vagal nerve stimulation to suppress NLRP3—combined with multi-omic profiling provides a practical, high-leverage way to personalize longevity care beyond traditional risk-factor management.
Actionable Takeaway
In patients with chronic inflammation or dysautonomia, add MMP-9 and homocysteine (along with ApoB, Lp(a), TGF-β1, and C4a when feasible) to baseline labs; if elevated, trial a noninvasive vagal nerve stimulation protocol to engage the cholinergic anti-inflammatory pathway and reassess biomarkers after 6–8 weeks.
2. The Human Upgrade: Biohacking for Longevity & Performance
Why Are Hackers Microdosing “Sex Drugs” Now? : 1425
Published: 2026-03-03
URL: Listen Here
Summary
This episode explores how precision medicine leverages multi-omics, exposome assessment, and autonomic modulation to individualize care, with practical discussion of peptides, low-dose pharmaceuticals (e.g., tadalafil), and advanced biomarkers beyond standard panels. The conversation emphasizes sequencing interventions for mitochondrial and vascular health, measuring transcriptomic responses to confirm epigenetic effects, and safeguarding data as personalized platforms mature.
Key Takeaways
Precision medicine requires an N-of-1, multi-omic approach (genomics, transcriptomics, proteomics, epigenetics, metabolomics, exposomics) to match the right intervention to the right person at the right time.
Autonomic modulation, particularly vagal nerve stimulation, can downregulate inflammatory pathways (e.g., NLRP3 inflammasome via the cholinergic anti-inflammatory pathway) and may improve longevity-relevant markers; EGCG was cited as a practical adjunct.
Microdosing or low-dose use of select pharmaceuticals (e.g., tadalafil for vascular tone) and emerging peptide therapeutics (e.g., BPC-157, KPV, CJC-1295 with ipamorelin/semorelin, PT-141) can be useful for targeted outcomes but should be sequenced thoughtfully; metformin and rapamycin are not universal longevity solutions.
Beyond routine labs, clinicians should consider biomarkers that reflect inflammation and vascular health such as homocysteine, MMP-9, TGF-β1, C4a, nitric oxide-related function, and even cell membrane lipidomics; low cerebral perfusion is common and clinically meaningful.
Biohacking technologies (e.g., intermittent hypoxic–hyperoxic training, photobiomodulation, PEMF, HBOT, acoustic shockwave) can be potent when applied in the right order and tracked with objective data; data privacy and ownership matter as multi-omic and exposome assessments scale.
Clinical Insight
Shifting from population averages to multi-omic, N-of-1 care—while actively modulating the autonomic nervous system—allows physicians to directly influence and verify changes in key inflammatory and vascular pathways (e.g., NLRP3, nitric oxide biology), improving precision and efficiency of interventions.
Actionable Takeaway
For patients with chronic inflammation, dysautonomia, or low perfusion, implement daily noninvasive vagal nerve stimulation (or paced-breathing/HRV training) for 10–20 minutes and track CRP/IL-6 and symptom changes; consider adding a well-tolerated green tea extract providing 200–400 mg EGCG/day as an NLRP3-modulating adjunct, checking for drug–supplement interactions.
3. The Human Upgrade: Biohacking for Longevity & Performance
Your AC Is Making You Dumber : 1444
Published: 2026-04-03
URL: Listen Here
Summary
This episode argues that air-conditioning and water‑damaged indoor environments expose occupants to mycotoxins that impair mitochondrial function, cognition, hormones, metabolism, and sleep, with variable susceptibility driven partly by HLA‑DR genetics. The hosts outline a cost‑conscious, stepwise approach to ‘detoxing’ homes and vehicles—fix moisture/HVAC, oxidize/degrade mycotoxins and VOCs, reseed with environmental probiotics, and protect high‑risk surfaces—alongside humidity and dust control. Limitations: many claims are experiential or product‑specific and not independently detailed in the episode; clinicians should interpret promotional elements cautiously and corroborate with evidence-based resources.
Key Takeaways
Toxic mold and their mycotoxins (e.g., ochratoxin A, zearalenone) are fat‑soluble mitochondrial poisons that can drive multisystem illness—neurocognitive deficits, sleep disturbance with vivid nightmares, mood/behavior changes, endocrine disruption (thyroid, estrogen dominance), weight gain, easy bruising, recurrent infections, and chemical sensitivity.
Susceptibility varies widely; genetics (e.g., HLA‑DR4 variants) and exposure history modulate risk, so one family member may be severely affected while others appear well. Brain SPECT data (Amen Clinics) suggest mold exposure can reduce prefrontal activity and cognition but may be reversible after remediation.
Built environments—especially HVAC systems, ductwork, dust, moisture-prone areas, and vehicles—are common and underrecognized exposure sources; ingestion via mold‑prone foods (coffee, grains, peanuts) also contributes.
Effective management pairs medical care with environmental strategies: identify and fix moisture sources, control indoor humidity (~40–50%), address HVAC and duct contamination, reduce dust, and consider staged decontamination (oxidizing fog/gas to degrade mycotoxins and VOCs, reseeding with environmental probiotics, and protective coatings on high‑risk surfaces).
Porous belongings can carry residual mycotoxins between homes; moving without decontaminating contents often perpetuates illness. Vehicles (cars/RVs) can be significant sources due to mold and VOCs; targeted ‘detox’ is different from standard detailing.
Clinical Insight
In patients with persistent, unexplained multisystem symptoms (fatigue/brain fog, sleep disruption, mood/behavior changes, weight dysregulation, chemical sensitivity), assessing and treating the home/vehicle environment—especially moisture control and HVAC/dust contamination—can be decisive for recovery from mycotoxin-related illness.
Actionable Takeaway
Screen for water‑damaged building exposure in symptomatic patients and recommend a basic home assessment: measure/maintain indoor humidity at 40–50%, use HEPA air filtration and HEPA vacuuming to reduce dust, inspect/clean HVAC and ducts, and initiate validated environmental testing (e.g., dust-based mycotoxin or ERMI/HERTSMI‑2) before escalating medications.
4. The Human Upgrade: Biohacking for Longevity & Performance
Your AC Is Making You Dumber : 1444
Published: 2026-04-03
URL: Listen Here
Summary
Dave Asprey and the SuperStratum team discuss how indoor mold and residual mycotoxins can impair mitochondrial function and contribute to wide-ranging symptoms, with variable patient susceptibility. They outline practical, staged approaches for homes and vehicles—addressing moisture control, HVAC/duct hygiene, dust removal, and targeted decontamination of mycotoxins/VOCs—to complement or follow traditional remediation.
Key Takeaways
The episode centers on indoor mold and mycotoxins as underrecognized drivers of diverse symptoms (fatigue, brain fog, sleep disturbance, mood changes, endocrine disruption, weight gain) via mitochondrial dysfunction and immune dysregulation.
Susceptibility varies widely; about 28% of people may carry HLA-DR4 variants associated with heightened inflammatory responses and reduced ability to clear fat-soluble mycotoxins, which helps explain why household members can be affected differently.
Common exposure sources include water-damaged buildings, high indoor humidity, HVAC/ductwork, dust accumulation, and vehicles; ochratoxin A (OTA) and zearalenone are highlighted as clinically relevant mycotoxins with thyroid and estrogenic effects, respectively.
Post-remediation illness can persist due to residual mycotoxins and VOCs on surfaces and in contents; the discussion emphasizes whole-home strategies: fix moisture sources, maintain 40–50% indoor RH, clean/coat HVAC and ducts, HEPA vacuum dust, and consider targeted decontamination approaches.
The guests discuss a staged approach they use (fogging/‘bombing’ to oxidize mycotoxins/VOCs, followed by environmental probiotics and durable anti-microbial coatings) as a lower-cost adjunct to traditional remediation, and note cars can require similar detox protocols.
Clinical Insight
In patients with otherwise unexplained neurocognitive, endocrine, sleep, or cardiometabolic complaints—especially with a history of dampness or water damage—environmental mycotoxin exposure is a plausible, often overlooked contributor; assessing susceptibility, the built environment (not just visible mold), and residual mycotoxins after remediation can materially influence outcomes.
Actionable Takeaway
Incorporate a brief environmental history and screening into visits for chronic, multisystem complaints: ask about water damage/musty odors, humidity levels, HVAC maintenance, visible condensation, dust burden, and car exposures; advise maintaining indoor RH ~40–50%, fixing moisture intrusions, HEPA vacuuming dust, servicing/cleaning HVAC and ducts, and consider referral to qualified mold assessment/remediation when indicated.
5. Huberman Lab
Cultivating Awe & Emotional Connection in Daily Life | Dr. Dacher Keltner
Published: 2026-04-06
URL: Listen Here
Summary
This episode details the science of awe—how shifting from narrow to vast perception, engaging with nature and music, and synchronizing in groups reliably evokes awe with tangible benefits across inflammation, vagal tone, pain, and well-being. Practical protocols (e.g., awe walks) offer clinicians scalable tools to augment care, while insights on social bonding (embarrassment/teasing) and carefully supervised psychedelic-assisted therapy highlight additional pathways to strengthen connection and resilience. Note: Some findings (e.g., long COVID improvements from brief daily awe) are preliminary and require further peer-reviewed validation.
Key Takeaways
Awe is a measurable, health-relevant state linked to increased vagal tone (HRV), reduced inflammation, lower physical pain, and reported improvement in long COVID symptoms from brief daily awe practices.
Shifting perceptual “aperture” from small to vast (for example, moving from focusing on a leaf to the canopy to the sky/horizon) reliably evokes awe and can recalibrate arousal, time perception, and self-focus toward equanimity.
An 8-week, once-weekly 20–30 minute “awe walk” intervention in older adults increased awe, kindness, and vast attention in daily life and reduced bodily pain, with longer-term follow-up suggesting brain health benefits.
Group synchrony (music, sport, dance, chanting, shared rituals) rapidly fosters bonding and collective identity, consistent with the concept of collective effervescence; embarrassment and prosocial teasing within groups signal commitment to norms and strengthen cohesion.
Psychedelics (classic serotonergic agents) can induce profound awe and may aid treatment-resistant conditions (e.g., end-of-life anxiety, depression, PTSD) when used in structured, safe, culturally respectful settings; microdosing lacks strong clinical evidence.
Clinical Insight
Awe can be deliberately elicited (nature, music, horizons, group synchrony) and functions as a low-cost, low-risk adjunct that measurably improves autonomic balance (vagal tone), reduces inflammatory load and pain, and supports mental health—making it a viable element to integrate into preventive care and rehabilitation plans.
Actionable Takeaway
Prescribe a weekly 20–30 minute awe walk for 8 weeks: ask patients to slow their pace and breath (prolonged exhalations), and to move attention from small to vast (e.g., a leaf → tree → treeline → clouds/horizon). Encourage one brief daily “micro-awe” (≈60 seconds via nature, music, or vistas). Track simple outcomes (pain ratings, mood/sleep, HRV if available) and consider adding music- or nature-based sessions for reinforcement.
6. Huberman Lab
Essentials: The Biology of Aggression, Mating & Arousal | Dr. David Anderson
Published: 2026-04-09
URL: Listen Here
Summary
This episode reviews the neurobiology of internal states governing aggression, mating, and arousal, emphasizing hypothalamic circuit logic, hormone signaling (notably estrogen pathways), and brain–body interactions. It highlights how social isolation engages conserved tachykinin mechanisms that amplify aggression and anxiety, suggesting concrete translational avenues (e.g., NK3 antagonists) while underscoring the clinical need to assess and address isolation.
Key Takeaways
Emotions are best understood as internal brain states (like arousal or motivation) that reshape input–output transformations of neural circuits; unlike reflexes, they often persist beyond the trigger and generalize across contexts.
Aggression is a heterogeneous set of behaviors supported by distinct but adjacent hypothalamic circuits (VMHvl): fear-related neurons can hierarchically suppress offensive aggression, and VMH integrates multisensory inputs while broadcasting low-dimensional ‘attack pressure’ signals widely.
Sex hormones do not map simply onto behavior: estrogen receptor–expressing neurons in male VMH are necessary for aggression, many testosterone effects are mediated via aromatization to estrogen, and in females, discrete VMH ER+ neuron subsets differentially control mating versus fighting.
Mating and aggression circuits exhibit reciprocal control: activating medial preoptic area (MPOA) ‘mating’ neurons can abruptly switch a male from fighting to courtship, whereas VMHvl ‘aggression’ neurons bias toward attack; PAG acts as a downstream ‘switchboard’ coordinating pain modulation and innate action patterns.
Social isolation robustly upregulates tachykinin signaling (e.g., tachykinin 2) across species, increasing aggression, fear, and anxiety; in mice, an NK3 receptor antagonist (osanotont) reverses isolation-induced phenotypes without sedation, highlighting a translational target for isolation-related psychopathology.
Clinical Insight
Social isolation is a potent, biologically mediated driver of negative affect and aggression—partly via tachykinin 2 signaling—with preclinical evidence that NK3 receptor antagonism can normalize isolation-induced aggression, fear, and anxiety without sedation; clinicians should treat isolation as a modifiable risk factor rather than a benign social state.
Actionable Takeaway
Routinely screen patients for social isolation (e.g., recent bereavement, living alone, limited social contact) and implement mitigation strategies—structured social engagement, therapy referrals, family/caregiver involvement, and follow-up touchpoints—especially in individuals showing increased irritability, anxiety, or aggression.
7. Huberman Lab
Essentials: The Biology of Aggression, Mating & Arousal | Dr. David Anderson
Published: 2026-04-09
URL: Listen Here
Summary
This episode synthesizes neural circuit, hormonal, and neuropeptide mechanisms underlying aggression, mating, arousal, and pain modulation. Key themes include hypothalamic control of offensive aggression and its suppression by fear, estrogenic regulation of male aggression, sex-specific VMH circuits for mating vs fighting, and tachykinin-driven effects of social isolation that are reversible with NK3R antagonism—findings with clear translational relevance for stress-related behavioral health.
Key Takeaways
Emotions are best understood as internal brain states (like arousal, motivation, sleep) that transform how inputs map to outputs; compared to reflexes, emotion states show persistence and generalization beyond the initial trigger.
Aggression is a behavior that can arise from different internal states (e.g., anger, fear, hunger); in mice, ventromedial hypothalamus (VMHvl) circuits drive offensive, positively valenced aggression, while adjacent hypothalamic fear circuits can hierarchically suppress fighting.
Hormonal control of aggression in males depends critically on estrogen receptor–expressing VMH neurons and aromatization of testosterone to estrogen; estrogen implants can restore aggression in castrated male mice.
Sex-specific neural architecture shapes behavior: in females, distinct estrogen receptor–positive VMH subsets separately control mating and fighting, and medial preoptic area (MPOA) ‘mating’ neurons can acutely suppress ongoing aggression (antagonistic VMH–MPOA interactions).
Social isolation upregulates tachykinin signaling (Tac2/neurokinin B) across the brain to increase aggression, fear, and anxiety; an NK3 receptor antagonist (osanetant) reverses these effects in mice. The periaqueductal gray (PAG) acts as a hub for innate behaviors and supports endogenous, state-dependent analgesia (e.g., during fear/defense).
Clinical Insight
Chronic social isolation induces a Tac2/NK3R-mediated, druggable brain state that heightens aggression, fear, and anxiety—highlighting both the clinical importance of assessing isolation/bereavement and the translational potential of NK3 receptor antagonism for stress-related behavioral dysregulation.
Actionable Takeaway
Routinely screen patients experiencing prolonged social isolation or bereavement for irritability, aggression, and anxiety, and implement structured social reconnection strategies (e.g., group therapy, regular follow-ups, community engagement) to mitigate these biologically primed risk states.
8. The Human Upgrade: Biohacking for Longevity & Performance
Why Doctors Can’t Fix Women in 2026 : 1446
Published: 2026-04-09
URL: Listen Here
Summary
This episode argues that modern care under-treats women’s hormones and that personalized, bioidentical HRT—especially estradiol and progesterone delivered vaginally at systemic doses—can be a cornerstone for restoring libido, cognition, mood, sleep, gut/gallbladder function, and overall vitality. The guests emphasize treating to clinical response (not just numbers), considering genetics and neurotransmitters, and leveraging nutrition (adequate protein, cautious fiber, iodine) while using testosterone judiciously. Note: Many claims were experiential and not directly cited; sponsor content and controversial viewpoints are included.
Key Takeaways
Personalized, bioidentical hormone replacement (estradiol, progesterone, ± testosterone) is presented as foundational for many symptomatic women—even premenopausally—with dosing guided by symptoms and function rather than fixed lab ‘norms’ or low-dose patches/pills.
Systemic vaginal delivery of estradiol and progesterone is advocated as higher bioavailability than oral/topical/patch routes, aiming to suppress elevated FSH and improve cognition, sleep, mood, gut/gallbladder function, and sexual function; oral progesterone’s sedating effects may arise from liver-derived metabolites.
Testosterone can benefit women’s libido and cognition but excess transdermal/injected T may increase DHT/aromatization or disrupt the vaginal microbiome; many women may normalize T by optimizing progesterone, with optional low-dose topical T for event-based arousal.
Diet and environment meaningfully influence hormones and neurotransmitters: prioritize adequate protein (supporting dopamine/COMT), avoid excessive insoluble fiber and certain phytoestrogens, consider iodine repletion for breast/uterine health, and be mindful of high-oxalate foods (e.g., matcha/spinach) implicated in kidney stones and tissue symptoms.
Evaluate and treat holistically: use FSH and symptom clusters to detect early dysfunction, recognize genetic/epigenetic differences (e.g., COMT) in hormone clearance, consider neurotransmitter support (dopamine/norepinephrine/serotonin), and avoid focusing on thyroid alone when sex-hormone deficits drive multi-system complaints.
Clinical Insight
For women with multi-system symptoms (mood, sleep, gut, libido, cognitive), adequately dosed, bioidentical estradiol plus progesterone—preferably via systemic vaginal delivery—and personalized titration to clinical response can restore function across brain, immune, gut, and sexual domains; labs (including FSH) inform but should not replace symptom-guided care.
Actionable Takeaway
In an appropriate symptomatic woman (even <45), obtain FSH, estradiol, progesterone, total/free testosterone, SHBG, DHEA-S, and thyroid panel; if findings and history suggest ovarian under-function, initiate a trial of bioidentical estradiol + progesterone via systemic vaginal delivery and titrate every 6–8 weeks to symptom relief while reinforcing adequate protein intake and avoiding excessive insoluble fiber.
9. The Human Upgrade: Biohacking for Longevity & Performance
Superhuman Contact Lenses, Motivation Supplement Stack, Cat Scratches Cause Brain Fog, Amino Acid Shortening Lifespan, and more... : 1448
Published: 2026-04-10
URL: Listen Here
Summary
This episode highlights overlooked inputs—stealth infections, amino acid balance, sensory light processing, micronutrient status, and olfactory cues—that materially affect cognition, motivation, and autonomic tone. It offers practical steps clinicians can use now: targeted PCR testing for Bartonella, judicious lab monitoring around tyrosine, nutrient stacking to bolster motivation, and low-cost sensory strategies to reduce cognitive and stress load.
Key Takeaways
Cat scratches/bites can transmit Bartonella, a stealth infection linked to chronic brain fog, mood instability, and fatigue; standard serology often misses it—PCR testing is preferred and may require referral to a Lyme-literate clinician.
A Mendelian randomization analysis (~270,000 participants) associates higher circulating tyrosine with nearly one year shorter lifespan in men (not women), potentially via myeloperoxidase-driven formation of inflammatory meta-tyrosine; consider measuring plasma tyrosine and phenylalanine and avoiding unnecessary tyrosine supplementation, especially in men.
Tinted contact lenses (Altius) reportedly reduce chromatic aberration by 53% and improve contrast by 20–30%, potentially lowering visual processing load and enhancing performance; spectrum-filtering eyewear (e.g., TrueDark) and screen apps (Flux/Iris) are adjuncts.
A randomized, placebo-controlled crossover trial from the University of the Philippines found a 4-week stack (taurine 2 g, methylfolate 800 mcg, P5P 50 mg, methylcobalamin 1 mg) increased effort-based motivation and reduced attention lapses, plausibly via astrocytic glutathione support of prefrontal function.
A Monell Chemical Senses Center analysis indicates a 30-second deep nasal inhalation of floral scents can lower heart rate by 5–10 bpm and shift autonomic tone toward parasympathetic; lavender has the strongest RCT support, but pleasant florals broadly appear effective.
Clinical Insight
In patients with persistent neurocognitive or mood symptoms and a history of cat scratches/bites, Bartonella infection is likely underrecognized; order a Bartonella PCR (not just serology) and consider referral to a tick-borne disease–literate clinician, as antibody tests can miss intracellular, tissue-resident infections.
Actionable Takeaway
For patients (especially men) using tyrosine-containing supplements or very high-protein diets, obtain a fasting plasma tyrosine and phenylalanine panel (Quest/LabCorp) and review inflammatory markers; avoid or reduce tyrosine supplementation if levels are high or the tyrosine:phenylalanine ratio approaches/exceeds 10:1.
10. The Human Upgrade: Biohacking for Longevity & Performance
CDC Director Jim O’Neill on Fixing America’s Broken Food Policy : 1449
Published: 2026-04-14
URL: Listen Here
Summary
This episode features Jim O’Neill outlining an HHS/CDC push to overhaul U.S. food guidance and aging research while refocusing CDC on infectious diseases. Highlights include whole‑food, higher‑protein dietary guidance with forthcoming RCTs on saturated fat, large ARPA‑H investments in causal aging biomarkers and organ bioprinting, and greater openness to AI, wearables, non‑pharma therapies, and GLP‑1s. Several claims are policy announcements or opinions presented without primary citations.
Key Takeaways
The guest describes newly released federal dietary guidelines that emphasize whole and minimally processed foods, higher protein intake (1.2–1.6 g/kg/day), and allow meat and full‑fat dairy, while de-emphasizing refined grains and ultra‑processed foods; randomized controlled trials on saturated fats are being initiated.
HHS is prioritizing rigorous replication and aging science, including a reported $144M ARPA‑H initiative to identify causal biomarkers of aging and an organ bioprinting program that has printed a pediatric heart/vasculature (not yet implanted).
CDC is being refocused on infectious diseases, with examples cited of assisting to contain Ebola (DRC) and Marburg (Ethiopia), alongside a stated goal of rebuilding public trust through transparency.
There is openness to evaluating non‑pharmaceutical interventions (e.g., ozone therapy) with the same standards as drugs, and to integrating AI and wearables into care and surveillance—paired with strong patient consent and privacy protections.
Clinical and policy notes include support for GLP‑1s in obesity treatment, an ongoing review of upper vitamin D limits, and improvements to school meals aligned with the updated guidelines.
Clinical Insight
A shift toward whole‑food, higher‑protein nutrition with a more individualized view of dietary fats suggests clinicians should reassess grain‑centric, low‑fat counseling and focus on reducing ultra‑processed carbohydrates while tailoring fat and protein recommendations to each patient’s metabolic risk and goals.
Actionable Takeaway
For adult patients—especially those with metabolic syndrome risk or sarcopenia—calculate and document an individualized daily protein target of 1.2–1.6 g/kg from whole‑food sources, pair this with counseling to minimize ultra‑processed/refined carbohydrates, and reassess lipid/metabolic labs to tailor fat recommendations.
11. Huberman Lab
How Women Can Improve Their Fertility & Hormone Health | Dr. Natalie Crawford
Published: 2026-04-13
URL: Listen Here
Summary
Dr. Crawford details a proactive, science‑based roadmap for improving female fertility and hormone health: use AMH and ovulation tracking to detect issues early, leverage high‑impact lifestyle changes and targeted supplements during the “trimester zero,” and apply appropriate medical tools without waiting for failure. She emphasizes avoiding cannabis and nicotine, practical contraception off‑ramp timing, and clarifies that egg freezing/IVF do not reduce ovarian reserve, while highlighting select promising but still investigational therapies. Note: Summary reflects the provided transcript and may omit topics discussed outside these excerpts.
Key Takeaways
Proactive fertility assessment matters: Anti-Müllerian Hormone (AMH) testing estimates ovarian reserve (not egg quality) and can guide life and treatment planning; it’s inexpensive (~$79) and useful even before trying to conceive.
Track ovulation, not just periods: A luteal phase <11 days is an early red flag for ovulatory dysfunction; avoid NSAIDs except during menses because they can block follicle rupture and ovulation.
Lifestyle and exposures strongly influence fertility and hormone health: Prioritize sleep (7–9 h), stress control, muscle building, anti-inflammatory nutrition, and toxin minimization; avoid cannabis and nicotine (both sexes), which impair gametes and increase miscarriage risk.
Evidence-supported preconception supplements: Begin a prenatal (with folate), CoQ10, omega-3 fatty acids, and vitamin D; for male partners, add L‑carnitine (± zinc/selenium). Consider low-dose melatonin (1–3 mg) for sleep/inflammation preconception, then stop in pregnancy.
Clinical nuances: Egg freezing/IVF do not deplete ovarian reserve; stop combined OCPs 3–6 months before trying to learn ovulation, remove levonorgestrel IUD ~6 months before attempting conception, and avoid Depo‑Provera if planning pregnancy within 1–2 years. Selective, emerging tools (e.g., GLP‑1s in insulin resistance/inflammation, intrauterine PRP for implantation failure) show promise; ovarian PRP and red light remain investigational.
Clinical Insight
Replace the “fail‑first” model with an early, data‑driven approach: normalize AMH screening and ovulation/luteal‑phase tracking for reproductive‑age women to surface problems sooner and tailor timely lifestyle, medical, or procedural interventions that can materially improve outcomes.
Actionable Takeaway
At routine visits for women who might want children, offer AMH testing and brief ovulation‑tracking education, and initiate a 60–90‑day preconception plan: sleep 7–9 h; avoid cannabis/nicotine and NSAIDs outside menses; start prenatal (folate), CoQ10 (200–400 mg/day), omega‑3 (1–2 g/day EPA+DHA), vitamin D per level; counsel partners to add L‑carnitine (≈2 g/day); reassess promptly if luteal phase <11 days, cycles irregular, age ≥35, or ≥2 pregnancy losses.
12. The Human Upgrade: Biohacking for Longevity & Performance
CDC Director Jim O’Neill on Fixing America’s Broken Food Policy : 1449
Published: 2026-04-14
URL: Listen Here
Summary
Acting CDC Director Jim O’Neill outlines a pivot in U.S. food policy toward whole foods and away from ultra‑processed, grain‑heavy patterns, alongside active trials reassessing saturated fats. He details federal investments in causal aging biomarkers via ARPA‑H, broader acceptance of AI and wearables (with consent) in care, a renewed CDC focus on infectious diseases, support for GLP‑1s in obesity management, and a review of vitamin D limits. Several points reflect evolving policy announcements described in the interview.
Key Takeaways
HHS/CDC leadership reports newly announced U.S. dietary guidelines that emphasize whole, minimally processed foods, reduce reliance on grains and ultra-processed foods, and affirm that meat and full‑fat dairy can fit into a healthy diet; randomized controlled trials on saturated fats are underway.
The government is prioritizing replication and rigor, including a $144M ARPA-H initiative to develop and FDA‑validate causal biomarkers of aging to enable surrogate endpoints for prevention and longevity therapies.
CDC is refocusing on infectious disease and highlights recent collaborations that contained Ebola (DRC) and Marburg (Ethiopia), while rebuilding public trust via transparency and focus.
There is openness to testing non‑pharmaceutical and biohacking innovations (e.g., ozone therapy) with the same scientific standards, and expanded use of wearables and AI for early detection and clinical decision support, with strong emphasis on privacy and informed consent.
GLP‑1 receptor agonists are supported as effective tools for obesity when paired with nutrition and fitness, vitamin D upper‑limit recommendations are under review, and school meals are viewed as a high‑leverage point for improving national nutrition.
Clinical Insight
Expect a policy shift in federal nutrition guidance—toward whole, minimally processed foods with adequate protein and without blanket avoidance of saturated fat/full‑fat dairy—which, combined with GLP‑1 use where appropriate, can reshape counseling and management of obesity and cardiometabolic disease.
Actionable Takeaway
Update nutrition counseling now: guide patients to prioritize whole foods and minimize ultra‑processed/refined grains, target 1.2–1.6 g/kg/day protein, individualize recommendations on saturated fat based on cardiometabolic risk, and routinely measure 25‑OH vitamin D with supplementation as needed under monitoring.
13. The Human Upgrade: Biohacking for Longevity & Performance
1 Cup Every Morning Helped Me Lose 100 Pounds (Drink THIS) : 1452
Published: 2026-04-19
URL: Listen Here
Summary
This episode is a first‑person narrative promoting butter/MCT coffee, intermittent fasting, and a high‑fat, low‑grain approach while labeling common nutrition beliefs as myths and de‑emphasizing exercise for fat loss. It reflects popular biohacking perspectives but provides limited primary evidence; clinicians may encounter patients adopting these strategies and should contextualize them within current guidelines and individualized risk assessment.
Key Takeaways
Host Dave Asprey attributes losing over 100 pounds to starting mornings with “butter coffee” (grass‑fed butter + MCT oil) and practicing intermittent fasting, emphasizing satiety, steady energy, and reduced cravings.
He presents nine “myths” he believes hinder weight loss: saturated fat is harmful; low‑fat diets are healthy; calories‑in/calories‑out drives weight change; frequent small meals boost metabolism; all vegetables are beneficial (citing anti‑nutrients in some); whole grains are healthy; fruit is universally healthy (warns about fructose); breakfast is essential; and exercise is the primary tool for fat loss.
Asprey advocates prioritizing saturated fats from grass‑fed animal sources and coconut oil, avoiding trans fats and processed seed/vegetable oils, minimizing grains and high‑fructose fruits, and selecting lower anti‑nutrient vegetables.
He claims mold/mycotoxins in some coffees drive jitters and poorer tolerance, recommending “clean” coffee; he also argues diet quality and fasting outweigh exercise for fat loss and warns that overtraining may elevate cortisol.
The episode is largely anecdotal and promotional, referencing his books and commercial products; specific primary research citations supporting many claims are not provided.
Clinical Insight
Patients may inquire about high‑fat morning beverages and time‑restricted eating to curb hunger and aid weight management; clinicians should individualize guidance and, if trialed, monitor cardiometabolic risk (e.g., LDL‑C/apoB, glycemia, liver enzymes) given that several assertions—especially high saturated fat intake and broad avoidance of plant foods/grains—diverge from prevailing evidence‑based guidelines.
Actionable Takeaway
When patients ask about “butter coffee” or intermittent fasting, offer a short, supervised 2–4 week trial of time‑restricted eating (e.g., 14–16 hour daily fast) focused on minimally processed foods; advise non‑caloric morning beverages in higher‑risk patients, track hunger/weight/glucose, and recheck lipids as indicated before making longer‑term changes.
14. The Human Upgrade: Biohacking for Longevity & Performance
Jason Fung: 3 Rules to Lose 50 Pounds Without Ever Counting a Calorie : 1453
Published: 2026-04-21
URL: Listen Here
Summary
Jason Fung contends that contemporary obesity is driven primarily by hedonic and conditioned hunger magnified by ultra-processed foods and pervasive eating cues, not by a simple excess of calories. He outlines three rules—ditch ultra-processed foods, reintroduce fasting windows, and engineer environments—to lower hunger and make weight loss sustainable, positioning GLP‑1 medications as appetite-lowering tools to use alongside real‑food and behavior change.
Key Takeaways
Hunger has three distinct drivers—homeostatic (physical), hedonic (pleasure), and conditioned (cue-driven/social)—and the latter two dominate modern overeating.
Ultra-processed foods are engineered to maximize reward and minimize satiety (rapid absorption, texture modifiers, emulsifiers, flavor enhancers), amplifying hedonic and conditioned hunger independent of calories.
Sustained weight loss rarely results from calorie restriction alone; approaches that reduce hunger (diet quality, meal timing/fasting, environmental redesign) work better. GLP-1 receptor agonists help mainly by suppressing appetite but require concurrent habit change for durability.
Fung’s three golden rules: eliminate ultra-processed foods; include consistent fasting periods (reduce meal frequency/snacking); and redesign schedules/environments to remove eating cues and food noise.
Behavioral and mindset tools—such as extinction and counter-conditioning, eating only at a table, and reframing ultra-processed items as “not food”—can deprogram conditioned hunger and reduce cravings.
Clinical Insight
For patients with obesity, target hunger biology and conditioned cues rather than caloric math: assess and modify diet quality (real food over ultra-processed), structure meal timing (fasting windows), and reshape social/environmental triggers; consider GLP-1 agents to reduce appetite while concurrently coaching durable nutrition and behavioral skills.
Actionable Takeaway
At the next visit, screen for the three hunger types and initiate a 4‑week protocol: eliminate ultra-processed foods; eat 2–3 real‑food meals within an 8–10‑hour window with no calories between; and remove eating cues (no eating in the car/TV, keep snacks out of sight). If on a GLP‑1, pair with nutrition/behavioral coaching to build lasting habits.
15. The Human Upgrade: Biohacking for Longevity & Performance
Jason Fung: 3 Rules to Lose 50 Pounds Without Ever Counting a Calorie : 1453
Published: 2026-04-21
URL: Listen Here
Summary
This episode reframes obesity care around managing hunger biology and learned cues rather than prescribing calorie restriction. Fung explains how ultra-processed foods and ubiquitous food cues amplify hedonic and conditioned hunger, and outlines three practical rules—cut UPFs, add fasting windows, and redesign environments—to align physiology and behavior. GLP-1 medications can help by suppressing hunger, but sustained success depends on concurrent nutrition and behavioral retraining.
Key Takeaways
Overeating is primarily a hunger problem—not a calorie problem—with three contributors: homeostatic (physical), hedonic (pleasure-driven), and conditioned (cue-driven) hunger; in modern environments, conditioned and hedonic hunger dominate.
Ultra-processed foods are engineered to maximize reward (rapid absorption, intense flavors, optimized texture) while minimizing satiety, reinforcing both hedonic and conditioned hunger and driving habitual overconsumption.
Calorie restriction alone fails long term because physiology adapts and hunger intensifies; focusing on reducing hunger signals via food quality, structured fasting, and behavioral strategies is more sustainable.
GLP-1 receptor agonists reduce hunger and can enable weight loss, but durable results require concurrent learning of real-food eating patterns and environment/cue redesign to prevent relapse when medications stop.
Dr. Fung’s three golden rules: (1) eliminate ultra-processed foods; (2) establish consistent fasting windows and stop constant snacking; (3) redesign schedules and environments to reduce food cues, using counterconditioning and extinction to retrain conditioned hunger.
Clinical Insight
For sustained weight loss, clinicians should target the biology and behavior of hunger—especially conditioned and hedonic drivers—by replacing ultra-processed foods with real foods, implementing time-based fasting windows, and modifying environments/cues; pharmacologic appetite suppression (e.g., GLP-1 RAs) can be an adjunct but must be paired with nutrition and behavior change to maintain results.
Actionable Takeaway
Start a two-week intervention: advise patients to remove ultra-processed foods from home/work, eat 2–3 whole-food meals daily with adequate protein and natural fats, avoid between-meal snacks, and keep a 12–14-hour overnight fast; restrict eating to a table (not cars/TV) and replace evening snacking with unsweetened tea to extinguish conditioned cues, then reassess hunger/craving patterns at follow-up.
16. The Human Upgrade: Biohacking for Longevity & Performance
Jason Fung: 3 Rules to Lose 50 Pounds Without Ever Counting a Calorie : 1453
Published: 2026-04-21
URL: Listen Here
Summary
Dr. Jason Fung reframes weight loss around hunger biology and environment, arguing that hedonic and conditioned hunger—amplified by ultra-processed foods and pervasive cues—drive overeating more than true physical hunger. Sustainable management targets appetite regulation (real food, fasting windows, environment design, behavioral techniques) and may incorporate GLP-1 therapy as a tool while patients build lasting dietary and behavioral skills.
Key Takeaways
Obesity is driven by three types of hunger—homeostatic (physical), hedonic (pleasure-driven), and conditioned (social/cue-driven)—with conditioned and hedonic hunger now dominating due to environment, marketing, and constant food cues.
Chronic calorie restriction fails long-term because appetite and hormones (e.g., insulin, GLP-1 pathways) govern intake and expenditure; GLP-1 receptor agonists work by lowering hunger but require concurrent nutrition and behavior change for durable results.
Ultra-processed foods (UPFs) are engineered to maximize reward (rapid absorption, flavor enhancers, emulsifiers/texturizers) and minimize satiety, amplifying ‘food noise,’ cravings, and overeating; additives like carrageenan/xanthan gum can worsen mouthfeel-driven intake and may irritate the gut.
Fung’s three golden rules: (1) eliminate UPFs in favor of real, nutrient-dense foods; (2) ensure an adequate fasting window and stop constant snacking; (3) redesign schedule and environment (eat at a table, avoid eating while driving/TV, manage cues) to reduce conditioned hunger.
Behavioral strategies such as counterconditioning (pairing cravings with aversive imagery) and extinction/substitution (e.g., tea instead of snacks while watching TV), plus a mindset shift to view UPFs as “not food,” help deprogram conditioned eating.
Clinical Insight
Effective obesity care centers on diagnosing and treating hunger dysregulation (hedonic and conditioned drivers) and hormonal responses to food, not prescribing simple calorie restriction; prioritize removal of ultra-processed foods, structured fasting/eating windows, and environmental cue control, using GLP-1s as adjuncts to reduce hunger while patients learn durable eating behaviors.
Actionable Takeaway
Start a 2–4 week ‘real food + fasting’ trial: remove all ultra-processed items and sweetened/‘diet’ beverages; eat 2–3 real-food meals daily emphasizing protein and natural fats; maintain a 12–16 hour overnight fast with no snacking; and restrict eating to a table—then reassess hunger, satiety, and weight at follow-up.
17. The Human Upgrade: Biohacking for Longevity & Performance
Inside Kambo: Poison, Purging, and The People Who Swear By It : 1455
Published: 2026-04-24
URL: Listen Here
Summary
This episode examines Kambo’s traditional origins, modern ceremonial use, administration, peptide-based mechanisms, safety profile, and preliminary human outcomes. It highlights practical risk-reduction (especially electrolyte management), underscores the paucity of rigorous clinical data, and discusses sustainability and training standards relevant to clinicians advising patients exploring Kambo.
Key Takeaways
Kambo (frog skin secretion from Phyllomedusa bicolor) is applied via superficial skin burns and is not a classical psychedelic; it induces a rapid, intense 20–30 minute experience marked by flushing, tachycardia, nausea/vomiting, sweating, shaking, transient facial swelling (“frog face”), and possible bowel movements or syncope.
Traditional Amazonian use centered on ‘hunting magic’ (adaptogenic effects like heightened perception and stamina); modern practice emphasizes ritual, trauma work, and broad wellness aims, with anecdotal utility reported for pain, autoimmune issues, infections, metabolic disease, and addiction.
Pharmacology involves at least 27 peptide analogs across eight families (e.g., opioid-receptor–active and vagal-acting peptides, antimicrobial peptides) producing vascular, GI, autonomic, and possible antipsychotic effects; however, rigorous human research on the full Kambo cocktail is sparse.
Safety hinges on preventing hyponatremia from overhydration (especially when stacked with low-salt ayahuasca dieta/fasting) and supervising to mitigate aspiration and falls; with careful screening, electrolyte management, and close monitoring, serious adverse events appear uncommon.
Emerging data (practice datasets, a post-session survey, and a prospective human study pending publication) suggest improvements in mood, mindfulness, happiness, pain, and fatigue after Kambo; sustainability and standardization remain challenges, spurring conservation work and attempts to characterize/synthesize peptide mixtures.
Clinical Insight
Kambo is a peptide-rich, non-psychedelic intervention with meaningful autonomic, GI, antimicrobial, and opioid-receptor effects that may yield short-term improvements in mood, mindfulness, and pain—yet its safe application in practice depends primarily on rigorous screening and proactive electrolyte management to prevent hyponatremia.
Actionable Takeaway
If a patient plans to undergo Kambo, counsel them to avoid overhydration: use salted fluids or oral electrolyte solution (e.g., add 1/4–1/2 tsp sea salt per liter of water), avoid low-salt/fasting protocols and stacking with ayahuasca within 24–48 hours, and ensure the session is supervised by a trained practitioner who monitors for syncope/aspiration.
18. Huberman Lab
Male Roles, Obligations and Options for Building a Fulfilling Life | Scott Galloway
Published: 2026-04-27
URL: Listen Here
Summary
This episode examines modern male roles and well-being, advancing a positive masculinity framework (provider–protector–procreator plus service) and concrete habits that build purpose, skills, and relationships. It highlights Big Tech’s role in compulsive use and isolation, advocates for mentorship and national service, and outlines policy levers (antitrust, algorithmic liability, age-gating) and personal behaviors clinicians can reinforce to improve mental health and social outcomes.
Key Takeaways
Galloway proposes a constructive masculinity code—provider, protector, procreator—augmented by service and the goal of creating “surplus value” (giving more than one takes).
Practical plan for struggling young men: reclaim screen time; train hard (≥3x/week); work outside the home (~30 hrs/week when feasible); engage weekly in team/service groups; and practice graded social “approaches,” embracing rejection as a skill-builder.
Big Tech and algorithmic feeds foster compulsive phone use, isolation, and polarization; policy remedies discussed include antitrust actions, algorithmic liability (Section 230 reform), and age-gating social media for minors.
Male mentorship and (ideally) national service are framed as high-yield solutions to purpose, skill development, and social cohesion—especially critical for boys lacking an involved male role model.
Societal/economic context matters: wealth transfer from young to old, higher-ed gatekeeping, and limited vocational on-ramps are linked to male underachievement and relationship/fertility headwinds; clinicians should recognize porn overuse as an under-researched, potentially demotivating behavior, while alcohol/THC can be net harmful or helpful depending on context and use patterns.
Clinical Insight
For young and midlife men, social isolation coupled with compulsive digital use (better conceptualized as an OCD-like compulsion loop than simple ‘dopamine hits’) is a potent driver of anxiety, depression, and suicidality; brief clinical screening and counseling that redirect time toward structured exercise, out-of-home work/school, service/mentorship, and graded real-world social engagement can meaningfully improve mental health and functioning.
Actionable Takeaway
In visits with adolescent and young adult males, add a 4-point screen—1) daily screen time and app limits, 2) exercise ≥3 days/week (resistance and/or endurance), 3) hours spent working or studying outside the home, 4) weekly group/service participation—then prescribe a 2–4 week trial to reallocate at least 8 hours/week from phone use to those activities and provide a mentorship or Big Brothers Big Sisters referral if a stable male role model is lacking.
19. The Human Upgrade: Biohacking for Longevity & Performance
The Strangest Thing I Do Every Morning for 15 Minutes | Brad Pitzele : 1458
Published: 2026-04-30
URL: Listen Here
Summary
This episode outlines how EWOT and red/near-infrared light therapy can be mechanistically complementary: exercise-driven hyperoxia improves oxygen delivery while PBM increases mitochondrial oxygen demand and nitric oxide–mediated microvascular perfusion. The approach targets endothelial and mitochondrial dysfunction implicated in fatigue, chronic inflammation, and recovery limitations, with a practical protocol of 15 minutes of EWOT followed by immediate PBM. Few specific clinical trials were cited during the conversation; recommendations were largely mechanistic and experiential.
Key Takeaways
Exercise with Oxygen Therapy (EWOT) delivers ~93% oxygen during 10–15 minutes of light-to-moderate exercise using a concentrator and large reservoir bag, leveraging exercise-induced increases in ventilation, heart rate, vasodilation, and pressure gradients to drive oxygen deeper into tissues than resting oxygen supplementation.
Chronic inflammation and endothelial dysfunction impair microcirculation (pseudo-hypoxia) even when pulse oximetry is normal; swollen endothelial cells and less-flexible RBCs limit capillary oxygen delivery, pushing cells toward anaerobic metabolism, ROS production, and a self-reinforcing inflammatory loop.
Red/near-infrared photobiomodulation (PBM) enhances mitochondrial function by increasing oxygen demand and releasing nitric oxide for vasodilation; stacking PBM immediately after EWOT (when circulation and tissue oxygen levels are elevated) amplifies outcomes (energy, sleep, pain, recovery).
A practical stack advocated: ~15 minutes of EWOT followed immediately by 10–20 minutes of red/NIR light (multiple red and NIR wavelengths) targeted to symptomatic areas or whole body to pair oxygen supply with mitochondrial uptake.
Potential use cases discussed include fatigue, long-COVID/lung injury, endothelial and microvascular dysfunction, ‘anaerobic’ infections (e.g., Lyme), and detox support; the episode’s claims were primarily mechanistic and experiential, with few specific trials cited.
Clinical Insight
Tissue-level hypoxia from microvascular/endothelial dysfunction can persist despite normal SpO2; combining EWOT to enhance oxygen delivery with photobiomodulation to increase mitochondrial oxygen utilization and nitric oxide–mediated perfusion may help break cycles of low energy, inflammation, and impaired recovery.
Actionable Takeaway
For appropriate patients, trial a stacked protocol: 10–15 minutes of moderate EWOT (reservoir-fed ~93% FiO2) followed immediately by 10–15 minutes of red/NIR photobiomodulation (e.g., 620–660 nm and 800–1050 nm) targeted to key regions (e.g., lungs, neck/shoulders, lower limbs), while monitoring HR/BP/SpO2 and tracking functional markers (symptoms, 6MWT/VO2 proxy, and if available pulse wave velocity). Screen for contraindications to high FiO2 and follow oxygen safety protocols.
20. The Human Upgrade: Biohacking for Longevity & Performance
The Strangest Thing I Do Every Morning for 15 Minutes | Brad Pitzele : 1458
Published: 2026-04-30
URL: Listen Here
Summary
This episode explores how EWOT and red/near-infrared light target complementary sides of cellular energetics: EWOT boosts oxygen delivery during exercise, while photobiomodulation increases mitochondrial oxygen use and nitric oxide signaling. By addressing endothelial/microcirculatory dysfunction and mitochondrial inefficiency—common in aging and chronic disease—the combined approach may enhance energy, recovery, and vascular health, with practical protocols feasible at home.
Key Takeaways
Exercise with Oxygen Therapy (EWOT) uses a concentrator and large reservoir to deliver ~93% oxygen during 15 minutes of moderate exercise, leveraging exercise-induced vasodilation and pressure gradients to drive oxygen deeper into hypoxic tissues.
Aging and chronic illness often feature microcirculatory dysfunction and endothelial swelling that block red blood cells from reaching capillaries, creating tissue-level “pseudo-hypoxia” despite normal pulse oximetry; mitochondria then shift to low-yield anaerobic metabolism with more inflammatory byproducts.
Red/near-infrared light (photobiomodulation) complements EWOT by increasing mitochondrial oxygen demand and efficiency (e.g., cytochrome c oxidase effects) and by promoting nitric oxide–mediated vasodilation, improving energy production and microvascular function.
Stacking protocol: complete a 15-minute EWOT session, then immediately apply red/near-IR light (10–15 minutes) to capitalize on elevated circulation and oxygen availability; simultaneous use is possible but less practical.
Discussed benefits include improved energy, sleep, pain, skin quality, recovery, and potential support in conditions with microvascular/mitochondrial dysfunction (e.g., Lyme, post-viral/long-COVID lungs), along with practical access to home EWOT systems and broad-spectrum red/IR devices.
Clinical Insight
Tissue hypoxia from microvascular and endothelial dysfunction can persist with normal SpO2 and underlies many chronic symptoms; combining strategies that enhance oxygen delivery (EWOT) with those that increase mitochondrial oxygen utilization and nitric oxide–driven vasodilation (red/near-IR light) may restore cellular energy and improve function in select patients.
Actionable Takeaway
For appropriately screened patients, implement a stack 3–5 times weekly: 15 minutes of EWOT at moderate exertion using a reservoir-fed concentrator (~93% O2), followed immediately by 10–15 minutes of red/near-IR photobiomodulation directed to priority regions (e.g., thorax for lung issues or large muscle groups); track response via symptoms (energy, sleep, pain) and, when available, vascular metrics (e.g., pulse wave velocity).
21. The Human Upgrade: Biohacking for Longevity & Performance
The Strangest Thing I Do Every Morning for 15 Minutes | Brad Pitzele : 1458
Published: 2026-04-30
URL: Listen Here
Summary
This episode explains how EWOT and red/near‑infrared light therapy can be combined to address mitochondrial dysfunction and microcirculatory ‘pseudo-hypoxia’ that underlie many chronic symptoms. The discussion emphasizes endothelial health, nitric oxide–mediated vasodilation, arterial stiffness (pulse wave velocity), and the lung’s role in detoxification, offering a practical sequencing strategy (EWOT, then PBM) to enhance energy, recovery, and tissue oxygenation. Limitations: the conversation is expert opinion–heavy and promotional in parts, and does not cite specific peer‑reviewed studies.
Key Takeaways
Exercise with oxygen therapy (EWOT) uses a concentrator and large reservoir (~93% O2) to deliver high oxygen flow during 10–15 minutes of moderate exercise, leveraging exercise-induced vasodilation and pressure gradients to drive oxygen deeper into tissues.
Stacking red/near-infrared photobiomodulation (PBM) immediately after EWOT exploits elevated circulation and oxygen availability to increase mitochondrial oxygen demand and efficiency, enhancing energy production, recovery, pain relief, and potentially sleep, skin, and sexual function via nitric oxide signaling.
Endothelial health and microcirculation are central: inflammation causes endothelial swelling and reduced RBC deformability, creating ‘pseudo-hypoxia’ (normal SpO2 but poor tissue oxygenation) that shifts mitochondria to inefficient anaerobic metabolism and a pro-inflammatory ‘doom loop.’
Arterial stiffness is an aging biomarker (e.g., pulse wave velocity); exercise and PBM can increase nitric oxide, improve vasodilation, and may support arterial flexibility and downstream tissue oxygenation.
Lungs are major detox organs (~70% of toxin elimination); adequate oxygen is required for biotransformation and repair. EWOT may support recovery in post-viral/lung injury states by improving cellular oxygenation and mitochondrial energy needed for healing.
Clinical Insight
Sequenced therapy—EWOT to rapidly elevate tissue oxygen supply followed immediately by PBM to raise mitochondrial oxygen demand—can help overcome tissue-level ‘pseudo-hypoxia,’ restore aerobic metabolism, and improve microcirculatory function in patients with chronic inflammation, endothelial dysfunction, or post-illness fatigue.
Actionable Takeaway
Implement a clinic protocol: 10–15 minutes of EWOT (reservoir-fed ~93% O2) at moderate intensity (elevated HR/respiratory rate) followed within 5 minutes by 10–20 minutes of PBM (combined red ~630–680 nm and near-infrared ~800–1050 nm) targeted to symptomatic regions (e.g., thorax for lung, large muscle groups, or generalized exposure). Monitor SpO2/HR/BP, start with conservative dosing, and track outcomes (e.g., 6MWT, symptom scores, VO2 max trend, pulse wave velocity/microvascular assessments). Screen for photosensitizing meds and cardio-pulmonary contraindications.
22. The Human Upgrade: Biohacking for Longevity & Performance
Eat These Foods + Spices for 8 Weeks To Get 3 Years Younger | Kara Fitzgerald : 1461
Published: 2026-05-05
URL: Listen Here
Summary
This episode highlights clinical and mechanistic evidence that diet rich in methyl donors and polyphenols—supported by foundational lifestyle practices—can reverse epigenetic age within weeks, with nutrients doing the ‘heavy lifting.’ It also explores the frontier of Yamanaka factor biology and PRC2-linked ‘programmatic’ aging, proposing that select polyphenols may partially mimic reprogramming effects. Limitations include multimodal design (potential confounding), reliance on specific clocks, and that ‘Yamanaka mimetic’ strategies are largely preclinical.
Key Takeaways
An 8-week randomized controlled dietary and lifestyle program emphasizing methyl-donor foods and polyphenol-rich ‘methylation adaptogens’ reduced biological age by over three years on the Horvath epigenetic clock in healthy middle-aged men; subsequent analysis suggested nutrients—especially dense polyphenols—were the primary drivers.
The protocol featured 7–11 cups/day of fruits, vegetables, herbs, and spices; methylation-supportive foods (e.g., leafy greens, eggs, beets, liver); and included meditation, sleep hygiene, and exercise, with the control group’s exercise likely making exercise effects a wash.
Polyphenols (e.g., EGCG from green tea; culinary herbs like rosemary, oregano, marjoram, thyme; and targeted options like urolithin A) may modulate gene expression and epigenetic marks; supplements can layer on top of diet for therapeutic dosing, though diet provides synergistic ‘information’ not captured by single compounds.
Emerging work on Yamanaka factors and polycomb repressive complex 2 (PRC2) suggests a ‘programmatic’ component of aging; early evidence indicates caloric restriction and potentially select polyphenols could act as ‘Yamanaka mimetics’ to nudge youthful epigenetic programs (largely preclinical at present).
First-generation clocks (e.g., Horvath) may capture aspects of programmatic aging; newer measures (e.g., DunedinPACE) are useful for tracking pace of aging. Case reports indicate women can also achieve meaningful bioage improvements with similar nutrition-forward protocols.
Clinical Insight
A targeted, food-first intervention emphasizing methyl-donor nutrients and high–polyphenol intake—augmented by basic lifestyle practices—can measurably and rapidly lower epigenetic age; in this cohort, the nutritional components appeared to account for most of the effect.
Actionable Takeaway
Implement an 8-week methylation-supportive nutrition plan (7–11 cups/day of diverse plants and polyphenol-rich herbs/spices; plus methyl donors like leafy greens, eggs, beets, and liver), alongside meditation and sleep hygiene; consider layering targeted polyphenol and metabolic supplements (e.g., EGCG, urolithin A, alpha‑ketoglutarate, sodium butyrate) as appropriate, and measure epigenetic age (e.g., Horvath/DunedinPACE) pre- and post-intervention to assess impact.
23. Huberman Lab
Essentials: Compulsive Behaviors & Deep Brain Stimulation | Dr. Casey Halpern
Published: 2026-05-07
URL: Listen Here
Summary
Dr. Casey Halpern outlines how compulsive behaviors arise from dysregulated cortico-striatal reward circuits and how neuromodulation—DBS, TMS, and MRgFUS—can be leveraged to treat refractory cases, with immediate efficacy in movement disorders and growing promise in psychiatry. The episode emphasizes personalized, symptom-evoked targeting and the integration of invasive recordings, noninvasive tools, and machine learning to advance precision therapies for OCD, addiction, and eating disorders.
Key Takeaways
Deep brain stimulation (DBS) and MR-guided focused ultrasound (MRgFUS) can precisely modulate small brain regions; DBS provides adjustable electrical therapy via implanted electrodes, while MRgFUS enables incisionless ablation—both are highly effective for tremor and are being explored for psychiatric indications.
Obsessive-compulsive disorder (OCD) involves dysregulation of cortico-striatal circuits, especially the ventral striatum/nucleus accumbens, which gate reward-seeking versus compulsive behaviors; similar circuitry underlies addiction and binge-eating.
First-line OCD treatments include SSRIs/tricyclics and exposure and response prevention (ERP) therapy; about 30% remain symptomatic, and in severe refractory cases, DBS or capsulotomy yields roughly 50% response rates but often with residual symptoms—highlighting the need for more precise, symptom-specific targeting.
Noninvasive neuromodulation is advancing: TMS is FDA-approved for depression, OCD, and nicotine addiction; MRgFUS is FDA-approved for essential tremor and tremor-dominant Parkinson’s disease, with research into modulatory ultrasound and blood–brain barrier opening; stereo-EEG (sEEG) is being leveraged to define better targets for psychiatric diseases.
Emerging approaches seek to detect and interrupt pathologic urges (e.g., craving/obsession cells) using intraoperative recordings, lab-based mood/craving provocation paradigms, and machine learning—aiming for closed-loop, personalized interventions; awareness helps less severe cases but is often insufficient for the most refractory patients.
Clinical Insight
Compulsive behaviors across OCD, addiction, and binge-eating share a core dysfunction in ventral striatal reward/limbic circuits (notably the nucleus accumbens); targeted and personalized circuit modulation—guided by symptom-evoked neural signatures—offers a path to improve outcomes beyond current ~50% response rates from conventional DBS/lesional approaches.
Actionable Takeaway
For patients with OCD who remain symptomatic after adequate SSRI/tricyclic trials and ERP, refer to a specialized neuromodulation center to evaluate FDA-cleared transcranial magnetic stimulation (TMS) for OCD and to discuss candidacy and expectations for investigational DBS/capsulotomy in severe, treatment-refractory cases.
24. Huberman Lab
Essentials: Compulsive Behaviors & Deep Brain Stimulation | Dr. Casey Halpern
Published: 2026-05-07
URL: Listen Here
Summary
This episode outlines how compulsive behaviors and OCD arise from dysregulated cortico–striatal–limbic circuits and how neuromodulation—from TMS to DBS and MRI-guided focused ultrasound—is being applied and refined to treat severe, refractory cases. It emphasizes circuit-specific targeting (e.g., ventral striatum/nucleus accumbens), closed-loop detection of craving/obsession signals, and the roles of ERP and pharmacotherapy as first-line treatments. Note: As an Essentials excerpt, procedural details and specific trial outcomes are summarized at a high level.
Key Takeaways
Deep brain stimulation (DBS) delivers targeted electrical stimulation via implanted leads; transient effects (e.g., brief laughter or panic) reveal proximity to limbic circuits and have informed psychiatric applications beyond movement disorders.
Obsessive-compulsive disorder (OCD) and related compulsive/impulsive syndromes involve hyperactive prefrontal/orbitofrontal regions and ventral striatal circuits (notably the nucleus accumbens) that gate reward and compulsion; circuit-informed targeting is central to therapy development.
First-line OCD care includes SSRIs or clomipramine (tricyclics) and exposure and response prevention (ERP); ~30% remain refractory, and current surgical options (DBS or capsulotomy) achieve about a 50% responder rate, with residual symptoms common.
Noninvasive neuromodulation is advancing: TMS is FDA-cleared for depression, OCD, and smoking cessation; MRI-guided focused ultrasound is FDA-approved for tremor and is being explored for modulatory (non-ablative) applications and potential psychiatric targets.
Closed-loop paradigms combining invasive recordings (e.g., stereo-EEG/DBS) with symptom or mood provocation can identify ‘craving/obsession’ signals (e.g., for binge eating) to personalize stimulation, while awareness-based therapies help many but often fail in the most severe, treatment-resistant cases.
Clinical Insight
Compulsive and impulsive disorders are circuit-based conditions of cortico–striatal–limbic networks; precise, and increasingly closed-loop, neuromodulation targeting the ventral striatum/nucleus accumbens can provide meaningful benefit for severe, treatment-resistant patients, while TMS offers an FDA-cleared, less invasive option for select indications.
Actionable Takeaway
Establish a referral pathway to a specialty center (functional neurosurgery/psychiatry) for patients with treatment-refractory OCD to discuss neuromodulation options—offer an FDA-cleared TMS trial first when available, and consider DBS or capsulotomy evaluation (or clinical trials) if nonresponsive.
25. The Human Upgrade: Biohacking for Longevity & Performance
Pandemic Fever Is BACK, Testosterone and Brain Tumors, Rabies, and Dog Flu : 1463
Published: 2026-05-08
URL: Listen Here
Summary
This episode synthesizes emerging signals in oncology and infectious disease: new data suggesting physiologic testosterone may restrain glioblastoma behavior, alongside multiple zoonotic threats (Influenza D, canine coronavirus HuPn-2018, Andes hantavirus) and a temporary disruption to U.S. rabies testing. The unifying message is proactive risk management—know patients’ biologic baselines (e.g., hormones), reinforce first-line defenses (mucosal immunity, sleep, stress), and act quickly when exposure windows are short (rabies, hantavirus).
Key Takeaways
NIH-funded Cleveland Clinic research reported that low testosterone may drive glioblastoma stemness and invasion, whereas restoring physiologic testosterone reduced tumor growth by ~38% and improved survival in models—challenging assumptions that lower androgens universally reduce cancer risk.
CDC has paused certain testing (including rabies), creating potential 1–2 week diagnostic delays; because rabies PEP is time-critical, suspected exposures warrant same-day ER initiation of prophylaxis without waiting for lab confirmation; ensure pets are vaccinated and consider pre-exposure prophylaxis when traveling to endemic regions.
A U.S. Supreme Court one-week stay preserved telehealth access to mifepristone pending rapid review; the legal reasoning could set precedents affecting FDA authority, telehealth, and access to therapies such as compounded peptides and bioidentical hormones.
University of Florida researchers highlighted two zoonotic risks: Influenza D circulating in U.S. cattle and a canine coronavirus (HuPn-2018) that has jumped to humans; no vaccines exist and population immunity is minimal—reassess raw milk risk and reduce close pet-lick exposure while strengthening mucosal immunity (sleep, stress control, vitamin D, zinc, fermented foods).
Andes hantavirus cases linked to a cruise ship off the Canary Islands underscore that this American strain can spread person-to-person and causes severe pulmonary syndrome with high case fatality; recognize early symptoms (fever, myalgias, abrupt fatigue) and pursue urgent evaluation after plausible exposure.
Clinical Insight
Maintaining normal physiologic testosterone may suppress glioblastoma aggressiveness by limiting tumor stemness and invasion, suggesting clinicians should consider comprehensive hormonal assessment—especially in men—when evaluating brain tumor biology and overall oncologic risk, while recognizing these are emerging data that do not alone warrant changes to standard cancer therapy without oncology guidance.
Actionable Takeaway
For any patient with a credible rabies exposure (e.g., bat contact, wild carnivore bite), initiate post-exposure prophylaxis immediately and do not wait for laboratory confirmation—verify current turnaround times at your state lab and proactively counsel patients traveling to endemic regions about pre-exposure vaccination and prompt care-seeking.
26. Huberman Lab
Essentials: Compulsive Behaviors & Deep Brain Stimulation | Dr. Casey Halpern
Published: 2026-05-07
URL: Listen Here
Summary
This episode reviews how neurosurgical and noninvasive neuromodulation tools can modulate cortico–striatal–limbic circuits driving compulsive and impulsive behaviors, with a focus on OCD, addiction, and binge eating. It emphasizes current standards (SSRIs/tricyclics and ERP), the limitations of outcomes in severe, refractory cases, and the promise of symptom-locked, circuit-guided targeting—potentially enabling future noninvasive, scalable treatments.
Key Takeaways
Deep brain stimulation (DBS) and MR-guided focused ultrasound (MRgFUS) can rapidly and powerfully modulate brain circuits; while established for tremor and Parkinson’s disease, these tools are being adapted to target limbic circuits implicated in compulsive and impulsive behaviors (e.g., OCD, addiction, binge eating).
OCD is best understood along a spectrum; first-line treatments include SSRIs/tricyclics and exposure and response prevention (ERP), yet ~30% remain refractory. For severe cases, DBS or capsulotomy yield about a 50% responder rate, often with residual symptoms—highlighting the need for more precise, symptom-locked targeting.
Compulsion and impulsivity share cortico-striatal-limbic circuitry (prefrontal/orbitofrontal cortex to basal ganglia/ventral striatum, especially nucleus accumbens) that gates reward seeking; identifying ‘craving/obsession-related’ neural signals intraoperatively and in lab paradigms is enabling symptom-specific neuromodulation.
Noninvasive neuromodulation is expanding: TMS is FDA-approved for depression, OCD, and nicotine addiction; MRgFUS is FDA-approved for tremor and is being explored for circuit modulation and blood–brain barrier opening. Stereo-EEG methods from epilepsy are informing circuit mapping for psychiatric indications to guide future noninvasive targets.
Improving patient awareness can help, but the most severe patients often remain refractory despite high awareness; combining rigorous circuit-guided neuromodulation with behavioral therapies and exploring AI/digital phenotyping to forecast high-risk states may provide scalable, clinically meaningful advances.
Clinical Insight
Compulsive and impulsive behaviors frequently arise from dysregulation within a shared cortico–striatal–limbic circuit—particularly the ventral striatum/nucleus accumbens—and targeted, symptom-linked neuromodulation (invasive now, potentially noninvasive later) can acutely alter these states, offering a path forward for patients with severe, treatment-resistant OCD and related conditions.
Actionable Takeaway
For patients with moderate-to-severe, treatment-resistant OCD (failed adequate SSRI/clomipramine trials and ERP), discuss risks/benefits and refer to a specialty center for consideration of neuromodulation—TMS (therapeutic and circuit-probing), DBS (e.g., ventral capsule/ventral striatum) or capsulotomy—and potential enrollment in circuit-mapping/SEEG-informed trials, while maintaining evidence-based behavioral therapy.
27. The Human Upgrade: Biohacking for Longevity & Performance
Pandemic Fever Is BACK, Testosterone and Brain Tumors, Rabies, and Dog Flu : 1463
Published: 2026-05-08
URL: Listen Here
Summary
This episode synthesizes timely health stories: a Cleveland Clinic/NIH report that normal testosterone may suppress glioblastoma stemness, a CDC testing pause that heightens urgency for immediate rabies PEP, legal moves affecting mifepristone telehealth access, and zoonotic threats from influenza D, canine coronavirus, and Andes hantavirus. The unifying theme is proactive risk management—optimizing hormonal and immune baselines and taking swift action after high-consequence exposures. Some details are host-reported and specific study links were not provided in-episode, which may limit independent verification.
Key Takeaways
NIH-funded Cleveland Clinic research reported that physiologic testosterone suppresses glioblastoma stemness and invasion; in models, restoring normal T reduced tumor growth by ~38% and improved survival—challenging the assumption that lower testosterone uniformly lowers cancer risk.
The CDC pause in rabies (and some other) testing is causing 1–2 week diagnostic delays; because post-exposure prophylaxis (PEP) must start promptly (≈10 days) and symptomatic rabies is nearly 100% fatal, suspected exposures warrant same-day ER care, with pets kept current on vaccines and travelers to endemic regions considering pre-exposure prophylaxis.
A temporary U.S. Supreme Court stay preserved mail/telehealth access to mifepristone pending further action—raising broader implications for courts influencing FDA-approved protocols and telehealth access across other therapies (e.g., compounded peptides, bioidentical hormones).
University of Florida researchers flagged two zoonotic risks: influenza D circulating in U.S. cattle and a canine coronavirus strain (CCoV-HuPn-2018) previously detected in humans; neither has established population immunity or vaccines, underscoring practical steps to bolster mucosal immunity and apply caution with raw milk and close pet contact (e.g., face-licking).
An outbreak of Andes hantavirus linked to a cruise near the Canary Islands highlights that this strain can spread person-to-person and causes severe HPS with high mortality; early symptoms (fever, myalgias, rapid-onset fatigue) after plausible exposure should prompt urgent evaluation and explicit hantavirus consideration.
Clinical Insight
Emerging evidence suggests hypogonadism may promote glioblastoma aggressiveness via androgen receptor signaling; in appropriate male patients, clinicians should assess total and free testosterone and avoid non-indicated androgen deprivation—coordinating closely with oncology before modifying cancer-related hormonal management.
Actionable Takeaway
For suspected rabies exposures (e.g., bat contact/bites), initiate CDC-recommended post-exposure prophylaxis immediately without waiting for laboratory confirmation, given current testing delays and the near-100% fatality once symptoms begin.
28. The Peter Attia Drive
#391 ‒ Colorectal cancer screening: importance of early screening, colonoscopy as a screening and preventive tool, and how to build a personalized strategy
Published: 2026-05-11
URL: Listen Here
Summary
This episode emphasizes that colorectal cancer is highly preventable due to its slow progression and the unique capacity of colonoscopy to both detect and remove precancerous polyps. It underscores the value of early, high-quality screening and clarifies the limitations of non-invasive stool and blood tests amid rising early-onset CRC. Note: this was a sneak peek; detailed recommendations and data are expanded in the full episode.
Key Takeaways
Colorectal cancer (CRC) is the second leading cause of cancer death in the U.S. (~55,000 deaths/year per American Cancer Society) yet is among the most preventable cancers.
CRC typically progresses slowly from normal tissue to benign polyp to precancerous polyp to malignancy over years to a decade or more, creating a long window for detection and intervention.
Colonoscopy is uniquely valuable because it can directly visualize and remove precancerous lesions, serving as both a screening and preventive tool.
A 2020 CDC estimate suggests about 68% of CRC deaths could be prevented with screening at recommended intervals; more aggressive, earlier, and higher-quality screening could drive mortality even lower.
The episode previews a practical framework: CRC biology, the rise in early-onset disease, how to prepare for and ensure a high-quality colonoscopy, appropriate intervals and trade-offs, and the capabilities and limitations of non-invasive stool- and blood-based tests.
Clinical Insight
Prioritizing timely, high-quality colonoscopy as the primary screening strategy—potentially starting earlier and tailoring intervals to risk—offers the greatest opportunity to prevent CRC by detecting and removing precancerous lesions before malignancy develops.
Actionable Takeaway
Proactively identify eligible average-risk adults in your practice and schedule screening colonoscopy as the first-line test, ensuring they receive clear, optimized bowel-preparation instructions to maximize exam quality and polyp detection.
29. The Human Upgrade: Biohacking for Longevity & Performance
The Real Reason She Loses Interest in Sex | John Gray : 1465
Published: 2026-05-12
URL: Listen Here
Summary
This episode explores how relationship dynamics and perceived safety may shape sex hormones and sexual desire, emphasizing communication tools to raise female estrogen and sustain male testosterone. It also presents provocative, largely anecdotal claims about prolactin in monogamy, semen retention, lithium orotate, and protein digestion, underscoring the need for clinical discernment and evidence-based integration.
Key Takeaways
Relational environment and perceived safety strongly modulate sex hormones: women’s estrogen tends to rise with feelings of safety/being heard, while men’s testosterone rises with perceived success/admiration—both influencing desire and sexual function.
In committed relationships, higher prolactin may dampen libido; maintaining polarity (high male testosterone alongside high female estrogen) via foreplay, cyclical distance/connection, and non-defensive listening may help sustain sexual interest.
Structured communication practices (e.g., brief, no-fix ‘listening sessions,’ avoiding “should” language, and specific help-asking rituals) are proposed to lower stress, raise female estrogen, and improve sexual satisfaction.
The episode advances several non-mainstream physiological claims (e.g., male anger linked to high estrogen, erections requiring rising estrogen, lithium orotate for dopamine/serotonin balance, pre-digested protein shakes for brain repair) largely without formal citations.
Reducing pornography/masturbation and practicing semen-retention are presented as strategies to improve male vitality, focus, and sexual performance, though clinical evidence remains limited.
Clinical Insight
For patients with low desire or erectile dysfunction in long-term relationships, psychosocial stress and pair-bond neuroendocrine factors (e.g., prolactin) may be pivotal; integrating relationship-focused counseling and stress-regulation strategies with standard medical evaluation can meaningfully impact outcomes.
Actionable Takeaway
Recommend a 2–4 week trial of nightly 10-minute ‘listening sessions’ in which the female partner shares day-to-day stressors (not partner-directed) and the male partner listens without fixing, followed by an affectionate hug and intentional, extended foreplay—while concurrently performing a routine medical workup for sexual dysfunction.
30. Health Longevity Secrets
The 91-Year-Old Physicist Betting His Body on Mitochondrial Transplant | John Cramer PhD
Published: 2026-05-12
URL: Listen Here
Summary
Physicist John Cramer, PhD, argues that aging is fundamentally a mitochondrial energy problem caused by mtDNA replication errors and clonal expansion, with many hallmarks of aging reflecting downstream energy triage. He describes early right-to-try experiences with platelet-derived mitochondrial transplantation, potential applications in acute care, and open issues such as haplogroup matching, scalability, and whether restoring energy alone can reverse age-related changes. Note: The discussion is hypothesis-driven, evidence remains preliminary, and parts of the transcript (especially the conclusion) appear informal and slightly truncated.
Key Takeaways
The episode advances a unifying hypothesis that aging is primarily an energy crisis driven by accumulating mitochondrial DNA (mtDNA) replication errors—especially deletion mutations—that clonally expand and impair cellular ATP production.
Many ‘hallmarks of aging’ may be downstream compensations to this energy shortfall; the body prioritizes energy for heart and brain while downregulating other energy-intensive maintenance and repair processes.
Historical free radical theories of aging overestimated reactive oxygen species (ROS) damage; evidence suggests mtDNA replication errors (not ROS) account for most mitochondrial genomic damage, with a notable acceleration around age ~65.
Maternal ‘winnowing’ in oocytes selects robust mitochondria for the next generation; in adults, declining mitophagy and energy constraints allow damaged mitochondria to accumulate, contributing to age-related dysfunction.
Mitochondrial transplantation (e.g., platelet-derived mitochondria/‘mitelets’) is an emerging therapy with early safety signals and reported organ-specific benefits in acute settings; key open questions include donor–recipient haplogroup compatibility, scalability, cost, and whether added energy alone can induce durable rejuvenation.
Clinical Insight
Mitochondrial dysfunction from clonally expanding mtDNA deletions may represent a central, upstream driver of aging biology; targeting cellular energetics (including investigational mitochondrial transplantation in acute organ injury) could influence outcomes more broadly than downstream hallmark-specific interventions.
Actionable Takeaway
For appropriate patients (e.g., acute myocardial ischemia or perioperative cardiac injury), stay current on and consider referral to clinical trials or compassionate-use programs investigating mitochondrial transplantation; in routine care, recognize and address factors that impair mitochondrial function while awaiting definitive evidence.
31. Microbiome Medics
Beyond the Gut: The Surprising Science of Respiratory Microbes with Dr. Michael Cox
Published: 2026-05-13
URL: Listen Here
Summary
This episode introduces the lung microbiome as a low-biomass, dynamic community largely seeded by the mouth/nose and shaped by a balance of deposition and clearance, with Streptococcus, Prevotella, and Veillonella commonly predominant. It highlights how smoking, pollution, and likely vaping/VOCs perturb this ecosystem and airway inflammation, outlines key methodological limits in current microbiome studies, and underscores pragmatic steps (notably smoking cessation and exposure reduction) while research advances toward functional, clinically predictive interventions.
Key Takeaways
The lungs host a real, low-biomass, dynamic microbiome shaped by continuous deposition (microaspiration/inhalation) and clearance; in health it is typically dominated by Streptococcus, Prevotella, and Veillonella, with uncertain in situ growth.
Respiratory sampling and measurement are challenging: lower-airway samples risk oral/nasal contamination, and standard sequencing yields relative (not absolute) abundances and limited strain-level resolution—hindering inference about competition, decreases, and function.
Modifiable inhaled exposures (cigarette smoke, air pollution, and likely vaping aerosols/metals and VOC-containing sprays) shift microbial communities and heighten airway inflammation; smoking cessation allows gradual reversion toward a healthier profile over years.
Upper-airway communities seed the lungs, but selective pressures in the airways favor certain taxa; oral health and dentition-associated microbes influence what reaches and persists in the lower airways.
Lifestyle factors (exercise, diet, avoidance of aerosolized chemicals) likely aid long-term respiratory resilience; physiotherapy benefits are clear in CF, while diet effects on the lung are mostly indirect/systemic and longer-term compared with local exposures.
Clinical Insight
For clinicians, the most actionable insight is that inhaled exposures—especially cigarette smoke (and likely vaping aerosols/metals) and VOC-rich sprays—measurably skew the respiratory microbiome and inflammatory milieu, influencing infection risk and chronic lung disease trajectories; stopping smoking can normalize the airway microbiome toward a healthy state over time.
Actionable Takeaway
At every respiratory visit, take and document an inhaled-exposure history (smoking, vaping, aerosolized cleaners/deodorants, occupational VOCs) and counsel cessation/substitution (e.g., replace sprays with liquid/solid products), as reducing these exposures can normalize the lung microbiome and lower airway inflammation.
32. The Second Opinion Podcast with Dr. Paul Kolodzik
EP 119: Recognizing Overmedication: How to Identify and Address It with Dr. Paul Kolodzik
Published: 2026-05-14
URL: Listen Here
Summary
This episode emphasizes recognizing and addressing overmedication in older adults, highlighting how polypharmacy—especially additive sedation—drives falls and functional decline. It also underscores real-world ED capacity challenges that complicate timely care. The discussion reinforces the importance of routine medication reviews and deprescribing in everyday practice to improve safety amid strained healthcare resources.
Key Takeaways
Hospital capacity constraints and nursing shortages are forcing emergency departments to board admitted patients and creating delays in transferring time-sensitive cases (e.g., STEMI needing emergent catheterization, leaking abdominal aortic aneurysm).
These system strains are occurring outside typical winter surges and may worsen with financial pressures on Medicare and hospital reimbursement.
Polypharmacy is common in older adults—often 15–20+ medications—driven by brief visits and a medication-first approach to symptoms.
Additive sedative effects from combinations of CNS-active drugs (e.g., benzodiazepines/anxiolytics, opioids, muscle relaxants, gabapentin, and some antidepressants) increase risks of impaired alertness, falls, and hip fractures.
Regular, deliberate scrutiny of each medication—favoring deprescribing, lifestyle measures, and regimen simplification—can meaningfully reduce harm in older patients.
Clinical Insight
In older adults, the cumulative CNS-depressant burden from multiple commonly prescribed medications is a major, modifiable driver of falls and subsequent morbidity; systematic deprescribing and minimization of sedatives can substantially improve safety and outcomes.
Actionable Takeaway
At the next visit with an older patient, conduct a targeted medication reconciliation focused on CNS-active and sedating agents (e.g., benzodiazepines, opioids, muscle relaxants, gabapentin, sedating antidepressants), verify current indications, and taper, discontinue, or substitute safer alternatives to lower fall risk.
33. The Human Upgrade: Biohacking for Longevity & Performance
Stop Wasting Your Gym Sweat (40 Minutes of This Wins Every Time) | Will Harlow : 1466
Published: 2026-05-14
URL: Listen Here
Summary
This episode emphasizes a pragmatic, minimal-effective-dose approach to fitness over 50: make resistance training the foundation, use brief daily balance drills, and de-emphasize long steady-state cardio. It highlights higher protein needs per meal in older adults, the utility of ~7,000 daily steps, and the value of addressing gait/vestibular issues to prevent falls and maintain independence. Note: the conversation includes personal opinions and commercial content; clinicians should verify claims and tailor recommendations to individual patients and guidelines.
Key Takeaways
For adults over 50, resistance training is essential and time-efficient: prioritize compound movements such as the goblet squat, farmer’s carry, and Romanian deadlift using a simple “3-2-1” plan (pick 3 exercises, perform them 2x/week, progress 1 variable each session) for a total of ~40 minutes per week.
Brief daily “exercise snacks” (30–60 seconds during routine activities) focused on balance and coordination meaningfully reduce fall risk and improve function; integrating strength and balance into daily life has been shown to cut falls by ~31%.
Chronic or excessive steady-state cardio (e.g., long runs) provides limited benefits for bone, muscle, and mobility and, in excess, may reduce muscle and bone mass; combine minimal-effective cardio with resistance work instead.
A daily step count of ~7,000 appears to capture most longevity benefit for many adults; the 10,000-step target originated from marketing, not science, and yields diminishing returns for most people.
Older adults experience anabolic resistance and generally need higher per-meal protein doses (≈40 g) to maximize muscle protein synthesis—especially when paired with progressive resistance training; address hydration and balance/vestibular training, and consider skilled gait/movement assessment if walking is painful.
Clinical Insight
For patients over 50, prescribing brief, progressive resistance training anchored in functional compound movements—augmented by daily balance ‘exercise snacks’—is a high-yield, low-time strategy to preserve muscle, bone, mobility, and independence while reducing falls; advising long-duration cardio alone is insufficient and may be counterproductive.
Actionable Takeaway
Initiate a twice-weekly 3-2-1 resistance plan: choose goblet squats, farmer’s carries, and Romanian deadlifts; perform 2 sessions per week (~20 minutes each), and at each session progress one variable (e.g., +1 rep, slight weight increase, slower tempo/technique). Add 1–2 daily 30–60 second balance snacks (e.g., single-leg stance, heel-to-toe ‘tightrope’ walk), and aim for ~7,000 steps/day as tolerated.
34. Health Longevity Secrets
EXPLAINER: What Happens to Your Body in 5 Days Without Ultra-Processed Food
Published: 2026-05-14
URL: Listen Here
Summary
This episode outlines a day-by-day timeline of physiologic changes that occur when ultra-processed foods are removed and replaced with whole foods, highlighting rapid improvements in glucose control, insulin sensitivity, blood pressure, inflammation, microbiome composition, and appetite regulation. The discussion is anchored by mechanistic data and the 2019 NIH metabolic-ward RCT, underscoring how even a brief intervention can meaningfully impact cardiometabolic risk.
Key Takeaways
Ultra-processed foods (UPFs) comprise over half of U.S. caloric intake and are linked to a 47% higher risk of heart attack or stroke among high consumers (American Journal of Medicine, 2026).
Within 24 hours of replacing UPFs with whole foods, postprandial glucose excursions drop substantially (meal order effect reported as a 73% AUC reduction), and sodium reduction triggers diuresis with early water-weight loss.
By 48 hours, insulin sensitivity begins improving (>30% reduction in post-meal insulin resistance with low-carb meals), the gut microbiome shifts toward SCFA-producing species within 24–72 hours, and taste receptor resensitization starts.
Around 72 hours, blood pressure begins to fall (6–8 mmHg within a week with ~4 g/day sodium reduction), inflammatory markers like CRP decline rapidly (35–43% in 7 days), and patients often report better energy, sleep, and mental clarity.
At 5 days, metabolic-ward RCT data show ad libitum intake is ~500 kcal/day lower on unprocessed vs. ultra-processed diets, with ~1 kg weight loss, reduced body fat, and improvements in HOMA-IR and triglycerides.
Clinical Insight
Short-term (≤5 days) elimination of ultra-processed foods and replacement with minimally processed, fiber-rich whole foods can yield rapid, measurable improvements in glycemia, insulin sensitivity, blood pressure, inflammation, and subjective well-being—making brief dietary trials a powerful clinical lever for metabolic and cardiovascular risk reduction.
Actionable Takeaway
Implement a 5-day whole-food reset for patients with metabolic risk: eliminate ultra-processed foods, reduce sodium by ~4,000 mg/day, and advise eating non-starchy vegetables and protein before carbohydrates at meals; have patients track home blood pressure and pre/post-meal glucose and reassess at day 5–7 to reinforce progress and adjust therapy if needed.
35. Huberman Lab
Essentials: Understanding & Controlling Aggression
Published: 2026-05-14
URL: Listen Here
Summary
This episode outlines the neurobiology of aggression, centering on VMHvl Esr1+ circuitry, the role of aromatized estrogen (not testosterone per se), and powerful context effects from stress hormones, serotonin, and photoperiod. It translates these mechanisms into practical levers—light exposure, heat therapy, cautious short-term ashwagandha use, and targeted supplementation (e.g., acetyl-L-carnitine in ADHD)—to help clinicians modulate aggression in practice. Note: The transcript is an excerpt and does not provide dosing specifics for all tools; clinicians should verify details before implementation.
Key Takeaways
Aggression comprises distinct forms—reactive, proactive, and indirect—and reflects activation of distributed neural circuits over time, not a single brain area or a momentary event.
Esr1 (estrogen receptor alpha)-expressing neurons in the ventromedial hypothalamus (VMHvl) are necessary and sufficient for attack behavior; optogenetic activation can instantaneously flip social behavior from mating to aggression and even elicit attack on inanimate objects via downstream outputs like the periaqueductal gray.
Testosterone does not directly cause aggression; its aromatization to estrogen within the brain drives aggression by acting on VMHvl Esr1+ neurons—context (stress hormones, serotonin, photoperiod) critically modulates this effect.
Elevated cortisol and reduced serotonin bias individuals toward aggression; longer daylight exposure (photoperiod) and behaviors that lower cortisol (e.g., heat exposure/sauna) can reduce this bias.
In a randomized, double-blind, placebo-controlled, double-crossover trial, acetyl-L-carnitine reduced aggression/impulsivity in children with ADHD, illustrating how targeted supplementation may modulate aggressive tendencies in specific contexts.
Clinical Insight
Aggression propensity is strongly context-dependent and biologically gated: stress-axis activation (higher cortisol) and serotonergic tone interact with aromatized estrogen acting on VMHvl Esr1+ neurons to shift behavior toward or away from aggression—making circadian/light, stress-reduction, and neurochemical interventions clinically relevant levers.
Actionable Takeaway
Advise patients with problematic irritability/aggression to obtain 10–30 minutes of outdoor morning light daily for 2–4 weeks (eyes exposed to natural light without sunglasses when safe), as a low-risk circadian intervention to lower cortisol/normalize neuromodulators and improve aggression regulation; reassess symptoms thereafter.
36. Huberman Lab
Essentials: Understanding & Controlling Aggression
Published: 2026-05-14
URL: Listen Here
Summary
This episode explains the neural circuitry of aggression, emphasizing VMHvl Esr1+ neurons and how aromatized estrogen, stress hormones, and photoperiod interact to gate aggressive behaviors. It reframes testosterone’s role, highlights rapid circuit-level switches between mating and attack, and offers practical strategies—light exposure, heat, selective supplementation—to modulate aggression. As an Essentials recap, some dosing specifics and full trial details are referenced from prior episodes or literature rather than provided exhaustively in-audio.
Key Takeaways
Aggression comprises distinct forms (reactive, proactive, indirect) and is generated by coordinated neural circuits—most critically estrogen receptor–expressing neurons in the ventromedial hypothalamus (VMHvl)—acting as fixed action patterns rather than isolated brain regions.
Testosterone does not directly cause aggression; its aromatization to estrogen within the brain activates VMHvl Esr1+ neurons to drive attack behaviors in both males and females.
Context strongly gates aggression: short photoperiods, elevated cortisol, and low serotonin increase the likelihood that estrogen will trigger aggression; long photoperiods (more daylight) mitigate this effect via changes in melatonin, dopamine, and stress hormones.
Optogenetic activation of VMHvl Esr1+ neurons can rapidly switch behavior (e.g., from mating to attack) and recruits downstream periaqueductal gray (PAG) circuits that organize motor patterns such as biting and limb striking.
Practical levers to reduce aggressive tendencies include lowering cortisol (morning sunlight exposure, sauna/hot baths; cautious, short-term ashwagandha) and, in ADHD, adjunct acetyl-L-carnitine has evidence for reducing aggressive/impulsive episodes in a randomized controlled trial.
Clinical Insight
Aggression propensity is a state-dependent output of hypothalamic circuits (VMHvl Esr1+), gated by steroid signaling and the stress–neurochemical milieu; assessing and modulating contextual factors—especially cortisol/photoperiod and serotonergic tone—can meaningfully alter aggressive behavior beyond simplistic attributions to testosterone or mood states.
Actionable Takeaway
Implement a structured morning light protocol for irritable or seasonally worsened aggression: advise 10–30 minutes of outdoor sunlight exposure within 1 hour of waking, daily for 2–4 weeks, to lower cortisol and shift neuromodulators toward reduced reactivity; reassess symptoms and add heat therapy (e.g., 20-minute sauna or hot bath sessions) as needed.
37. This Week in Cardiology
May 15, 2026 This Week in Cardiology
Published: 2026-05-15
URL: Listen Here
Summary
This episode reviews new evidence that strengthens the role of digoxin in reducing heart-failure events (particularly in AF), challenges binary coronary physiology thresholds through ORBITA FIRE’s individualized, exercise-sensitive angina metrics, and updates HCM risk stratification by prioritizing CMR-derived scar and volumetrics over legacy risk scores. It also highlights concerning trends in TAVR use among younger patients where long-term durability remains uncertain, underscoring the need for guideline-concordant heart-team decisions.
Key Takeaways
DIG-RHD (JAMA): In >1,700 patients with symptomatic rheumatic heart disease, digoxin reduced the composite of all-cause death or new/worsening heart failure by 18% (HR 0.82), driven by fewer heart-failure events; benefits were strongest in those with baseline atrial fibrillation, and stopping digoxin was associated with worse outcomes.
Prior and contemporary RCT data align: DIGIT-HF (digitoxin in HFrEF) and the historic DIG trial both showed reductions in heart-failure hospitalizations; withdrawal data from RADIANCE highlights hazards of stopping digoxin.
ORBITA FIRE (Circulation): The physiologic thresholds (FFR/RFR) that actually trigger angina are far lower than standard cut points (e.g., FFR ~0.29 at rest), highly individualized, and shift with exercise; patients with lower thresholds had more reproducible angina and derived the greatest symptomatic benefit from PCI—challenging binary FFR <0.80 decision rules.
HCM risk stratification (JAMA): CMR metrics (LGE% of LV mass, LV volumes) and NT-proBNP outperformed the ESC 2014 HCM risk score when modeled together; LGE ≥9% identified higher risk (lower than the 15% threshold in current AHA/ACC guidance).
TAVR in patients <65 years (Circ: Cardiovascular Interventions): Use rose to 37% of AVR procedures by 2020 with a modest decline to 29% by 2024 despite guidelines favoring SAVR in low-risk young patients; concerns persist about valve durability, difficult surgical explants, and heart-team decision dynamics.
Clinical Insight
Digoxin remains a useful, inexpensive adjunct in heart failure—especially with atrial fibrillation—reducing heart-failure events without mortality harm in randomized trials; clinicians should avoid routine discontinuation in stable patients given signals of harm with withdrawal.
Actionable Takeaway
For a stable heart-failure patient with atrial fibrillation already on digoxin, do not stop it routinely; if considering changes, reassess rate-control needs and alternatives first, and if a change is unavoidable, institute close follow-up for early signs of decompensation (renal function, electrolytes, symptoms).
38. The Human Upgrade: Biohacking for Longevity & Performance
Semen Switch, Chewing Gum, Creatine Cheat, Cancer Plants, and Bedtime Risk : 1467
Published: 2026-05-15
URL: Listen Here
Summary
This episode spotlights emerging findings in biohacking and translational science: creatine’s cognitive support during acute sleep loss, hidden microplastics from chewing gum, the cardiovascular risks of irregular sleep timing, a pathway to biosynthesize a potentially anticancer plant alkaloid, and a reversible, nonhormonal target for male contraception. Clinically, the strongest near-term implication is to prioritize sleep regularity as part of cardiovascular prevention while monitoring the other lines of research for future translation.
Key Takeaways
Acute creatine supplementation (≈10–15 g monohydrate) before anticipated sleep deprivation preserved up to ~12% more cognitive performance versus placebo in a randomized double-blind crossover trial of 29 adults; women and people with lower baseline brain creatine (e.g., vegetarians/vegans) appeared to benefit more.
Commercial chewing gums—both synthetic and those marketed as ‘natural’ or ‘plastic-free’—shed hundreds to ~3,000 microplastic fragments per stick into saliva; while direct human harm at these doses is unproven, microplastics can accumulate and provoke inflammation in models.
Irregular bedtimes combined with short sleep roughly doubled the 10-year risk of major cardiovascular events in a Finnish cohort, using accelerometer-verified sleep timing at age 46 with registry follow-up—underscoring circadian regularity as a cardiovascular risk factor.
University of British Columbia researchers mapped the genome of a kratom-related plant (reported as Mitrogena parvifolia) and elucidated the biosynthetic pathway for mitraphylene, enabling potential bioreactor production; this is an early drug-discovery step, not a clinical therapy endorsement.
Cornell researchers used the small molecule JQ1 to reversibly suppress spermatogenesis in mice by inhibiting the testis-specific protein BRDT without altering testosterone; fertility returned after stopping, supporting a viable nonhormonal, reversible male-contraception target.
Clinical Insight
Objective sleep-timing irregularity—especially when paired with short sleep—is a clinically meaningful, modifiable cardiovascular risk factor that warrants routine assessment and counseling alongside traditional risk management.
Actionable Takeaway
Screen patients for bedtime variability (e.g., with a brief sleep history or wearable data) and counsel them to maintain a consistent 90-minute bedtime window every night—including weekends—to reduce cardiometabolic risk.
39. The Human Upgrade: Biohacking for Longevity & Performance
Semen Switch, Chewing Gum, Creatine Cheat, Cancer Plants, and Bedtime Risk : 1467
Published: 2026-05-15
URL: Listen Here
Summary
This episode reviews studies on creatine’s cognitive support under acute sleep loss, microplastic exposure from chewing gum, the cardiovascular risks of irregular bedtimes, plant alkaloid biosynthesis enabling anticancer drug discovery, and a reversible nonhormonal male contraceptive target. The unifying theme is that seemingly neutral habits or exposures can carry measurable biological effects, with particular clinical relevance for circadian consistency. Limitations: the transcript lacks formal citations and may contain transcription errors in compound or organism names; verify primary sources before changing practice.
Key Takeaways
A single moderate dose of creatine (~14 g) preserved up to ~12% more cognitive performance during 21 hours of sleep deprivation in a double-blind crossover trial; women and people with lower baseline brain creatine (e.g., vegetarians/vegans) appeared to benefit more.
Chewing gum (synthetic and products marketed as natural/plastic-free) shed hundreds to ~3,000 microplastic fragments per stick into saliva; detected polymers included polyethylene and polystyrene, highlighting a previously underrecognized exposure source.
Objectively measured irregular bedtimes combined with shorter sleep were associated with about double the risk of major cardiovascular events over a decade in a Finnish cohort, underscoring the clinical importance of sleep timing regularity.
UBC researchers mapped a chromosome-level genome and decoded the biosynthetic pathway for a rare spirooxindole alkaloid (Mitraphylene) implicated in anti-tumor and anti-inflammatory activity, enabling potential scalable bioproduction; this is an early-stage drug discovery lead, not a recommendation to use kratom or related supplements.
Cornell researchers demonstrated reversible, nonhormonal male contraception in mice by inhibiting the testis-specific protein BRDT with JQ1: spermatogenesis stopped during treatment and fertility recovered after cessation with healthy offspring; translational safety and long-term effects require further study.
Clinical Insight
Sleep regularity—not just duration—is a modifiable risk factor linked to major cardiovascular events; counseling patients to maintain consistent bedtimes should be incorporated into cardiovascular risk reduction strategies.
Actionable Takeaway
Ask patients to set and adhere to a fixed 90-minute bedtime window every day (including weekends) and reassess sleep timing variability after 4–8 weeks; for higher-risk individuals, consider actigraphy or validated wearable data to quantify and address irregularity.
40. The Human Upgrade: Biohacking for Longevity & Performance
Semen Switch, Chewing Gum, Creatine Cheat, Cancer Plants, and Bedtime Risk : 1467
Published: 2026-05-15
URL: Listen Here
Summary
This episode reviews new research spanning acute creatine use for sleep-deprivation resilience, unrecognized microplastic exposure from chewing gum, the cardiovascular risks of irregular sleep timing, plant-derived drug discovery via kratom alkaloid biosynthesis, and a reversible, non-hormonal target for male contraception. The themes emphasize measurable exposures and behaviors that affect health now (e.g., sleep regularity, microplastics) and pipeline advances likely to influence future oncology and reproductive therapeutics.
Key Takeaways
Acute creatine supplementation (~10–15 g monohydrate) preserved up to ~12% more cognitive performance during 21 hours of sleep deprivation in a double-blind crossover trial; benefits appeared greater in women and those with lower baseline brain creatine (e.g., vegetarians/vegans).
Chewing gum—both synthetic and products marketed as “natural” or “plastic-free”—shed hundreds to ~3,000 microplastic fragments per stick into saliva during chewing, adding a largely unrecognized exposure source.
Objectively measured irregular bedtimes combined with short sleep duration were associated with approximately double the risk of major cardiovascular events over a decade, underscoring circadian regularity as a modifiable risk factor.
UBC researchers mapped the genome of Mitragyna parvifolia and decoded the biosynthetic pathway for the alkaloid mitraphylline, enabling potential bioreactor-scale production; this is a drug discovery pipeline advance, not evidence that kratom treats cancer.
Pharmacologic inhibition of the testis-specific protein BRDT with JQ1 in mice produced a reversible, non-hormonal “on–off” switch for spermatogenesis, restoring fertility after treatment cessation and suggesting a viable target for male contraception.
Clinical Insight
Sleep timing regularity is an independent, modifiable cardiovascular risk factor: patients with highly irregular bedtimes and short sleep had roughly double the rate of major cardiovascular events when sleep timing was objectively measured, supporting routine assessment and counseling on circadian consistency.
Actionable Takeaway
Incorporate a brief sleep-timing screen (e.g., ask about bedtime variability and weekend ‘social jetlag’) and counsel patients to maintain a consistent 90-minute bedtime window across all days, including weekends, as part of cardiovascular risk reduction.
41. The Human Upgrade: Biohacking for Longevity & Performance
The 4,000-Year-Old Asian Focus Drug That Is Not A Drug : 1468
Published: 2026-05-17
URL: Listen Here
Summary
This episode explains how pairing L-theanine with caffeine can produce a ‘calm focus’ state by aligning beta and alpha brain activity, with practical guidance on dosing, timing, and daily limits. It emphasizes that sleep quality, stress reduction, and simple focus rituals are essential to realize the full cognitive benefits of the stack.
Key Takeaways
Combining L-theanine with caffeine can promote a calm, sustained focus by balancing beta (alert) and alpha (calm/engaged) brain activity; a typical sweet spot is an L-theanine:caffeine ratio of about 2:1.
Dosing and timing matter: many adults do well with 50–150 mg caffeine per focus session paired with 100–300 mg L-theanine, taken together (within ~10 minutes) and allowing ~20–30 minutes for onset.
Daily caffeine should generally be managed to ~100–300 mg (upper limit around 400 mg/day for most adults per cited guidance), and intake should be earlier in the day (switch to decaf after ~2 p.m.) to protect sleep.
Lifestyle context is critical: adequate sleep, brief recovery breaks (1–5 minutes of slow breathing, walking, or light movement hourly), reduced notifications, and a simple focus ritual enhance the stack’s effectiveness.
Product quality and context influence outcomes: avoid high-sugar add-ins and low-quality blends; the host asserts mold toxins in coffee can impair performance and promotes “clean” coffee and light-filtering glasses as supportive tools.
Clinical Insight
A timed, 2:1 L-theanine-to-caffeine stack can meaningfully improve attentional control and reduce caffeine-related jitter—particularly in anxiety-prone or caffeine-sensitive individuals—while preserving alertness, provided sleep and stress are reasonably managed.
Actionable Takeaway
For patients who use caffeine for concentration, trial a morning focus stack of ~100 mg caffeine plus ~200 mg L-theanine taken together, begin focused work 20–30 minutes later for 60–90 minutes, insert 1–5 minute movement/breathing breaks each hour, and avoid caffeine after mid-afternoon to protect sleep.
42. Docs Who Lift
Are GLP-1 Medicines Shredding Your Bones? Here Is What the Actual Evidence Says With Dr. Susan Brian
Published: 2026-05-18
URL: Listen Here
Summary
This episode reviews evidence on GLP-1 receptor agonists and bone health, clarifying that most bone concerns reflect weight-loss–related unloading rather than a direct drug effect. Data in type 2 diabetes are broadly reassuring, while an elderly cohort signal and the degree/speed of weight loss justify resistance training, nutrition support, and DXA monitoring; further research is needed in older/frail populations and newer incretin combinations.
Key Takeaways
Current evidence does not show a direct bone-harming effect of GLP-1 receptor agonists; preclinical and mechanistic data suggest they may favor osteoblast activity and reduce osteoclast activity. Bone concerns largely stem from weight-loss–related reductions in mechanical loading.
In type 2 diabetes trials/meta-analyses, GLP-1 RAs are neutral to possibly protective for fractures; however, a recent retrospective Israeli cohort in older adults suggested a modest increase in fragility fractures versus other diabetes drugs, underscoring the need for vigilance in frail/elderly patients.
The magnitude and speed of weight loss correlate with bone mineral density (BMD) decline; adding resistance training preserves BMD during GLP-1–induced weight loss (e.g., liraglutide plus structured exercise maintained BMD compared with liraglutide alone).
Bone-protective management during pharmacologic weight loss includes moderate-intensity resistance training 2–3 days/week, daily weight-bearing activity (e.g., walking/stairs), adequate calcium and vitamin D intake, avoidance of rapid loss (>~0.5–1% body weight/week), and minimizing smoking/alcohol.
Consider baseline and follow-up DXA (DEXA) in midlife or high-risk patients initiating potent weight-loss therapy; when indicated, osteoporosis medications (e.g., romosozumab followed by zoledronic acid, or bisphosphonates/denosumab) effectively reduce fracture risk.
Clinical Insight
The primary bone risk with GLP-1 therapies arises from rapid, substantial weight loss (reduced skeletal loading), not from a direct drug effect; pairing treatment with resistance training, nutritional optimization, and bone monitoring mitigates this risk.
Actionable Takeaway
Obtain a baseline DXA when starting a GLP-1 RA for weight loss in midlife or higher-risk patients, prescribe a specific resistance-training plan (2–3 sessions/week, 8–12 reps to near-failure per set), ensure calcium/vitamin D sufficiency, target ≤1% body-weight loss per week, and repeat DXA in 12–24 months.
43. The Peter Attia Drive
#392 - Genetic testing: when it’s valuable, how to choose the right test, and what to do with the results
Published: 2026-05-18
URL: Listen Here
Summary
Peter Attia outlines a practical framework for using genetic testing judiciously: prioritize phenotypic data, reserve testing for high-yield indications (hereditary cancer, pharmacogenetics, select cardiac and monogenic disorders), and match the test type to the clinical question. He cautions against overinterpreting consumer SNP and nutrigenomic panels, emphasizes informed consent and privacy, and stresses that results should meaningfully change management or planning.
Key Takeaways
Genetic testing is largely probabilistic, not deterministic; in most common conditions, direct phenotypic measurement (e.g., ApoB/LDL-C, blood pressure, Lp(a), imaging) is more actionable than genotype alone.
Greatest clinical utility lies in high-penetrance hereditary cancer panels (e.g., BRCA1/2, Lynch) and targeted pharmacogenetics (e.g., CYP2C19–clopidogrel, HLA-B*58:01–allopurinol); selected inherited cardiac syndromes and monogenic lipid disorders (e.g., FH, rare SCARB1 variants) are additional use cases.
ApoE4 status meaningfully shifts Alzheimer’s risk but is not destiny; it can guide planning and may prompt more aggressive management of modifiable risk factors while therapeutics evolve.
Match the test to the clinical question: favor targeted single-gene or disease-specific panels when indicated; recognize limitations of consumer SNP tests and many nutrigenomic/‘detox’ panels (e.g., MTHFR, COMT), which have low effect sizes and poor actionability.
Interpret results deliberately: a negative test is not a clean bill of health, psychological impacts matter, use CLIA-certified labs with clear privacy policies, and ensure that any result leads to a concrete management plan.
Clinical Insight
For most patients, phenotype-first evaluation outperforms broad genetic screening; reserve clinical-grade genetic testing for scenarios where a high-effect variant or pharmacogenetic result will change management, and choose the narrowest validated test that answers the specific clinical question.
Actionable Takeaway
Before prescribing allopurinol, order HLA-B*58:01 testing to avoid potentially life-threatening hypersensitivity; document results and select alternative urate-lowering therapy if positive.
44. Lifespan with Dr. David Sinclair
Season 2 Official Trailer: Lifespan with Dr. David Sinclair
Published: 2026-05-18
URL: Listen Here
Summary
This trailer introduces Season 2 of Lifespan with Dr. David Sinclair, emphasizing biological age as a key predictor of health and the potential to slow or reverse aging processes. It highlights emerging tools to measure intervention impact and invites clinicians and the public to engage with a longevity-focused community. As a promotional trailer, it does not provide detailed protocols or specific study data.
Key Takeaways
Biological age, rather than chronological age, better predicts both lifespan and healthspan.
Aging is the leading risk factor for cancer, cardiovascular disease, and dementia, and may be modifiable.
New technologies allow objective measurement of whether longevity interventions are working.
It is valuable to start longevity-focused practices at any age, with the goal of adding 10–20 years of healthy life.
Lifespan aims to provide unique, factual longevity information and build a community that supports medical research.
Clinical Insight
Reframing aging as a modifiable driver of disease suggests integrating biological-age assessment and aging-targeted prevention strategies into clinical practice to improve long-term outcomes.
Actionable Takeaway
Offer or refer interested patients for validated biological-age/healthspan assessments to establish a baseline and track response to evidence-based interventions over time.
45. Huberman Lab
How to Overcome Social Anxiety | Dr. Nick Epley
Published: 2026-05-18
URL: Listen Here
Summary
This episode reviews the science of social connection and how misbeliefs about others’ receptivity fuel social anxiety and isolation. Dr. Epley details why authentic, real‑world exposure—not simulation—updates those beliefs, how voice and eye gaze convey mind and humanize others, and why small, daily connections meaningfully improve mental and physical health.
Key Takeaways
People systematically underestimate how positively others will respond to friendly outreach; graded, real‑world exposure (not simulated) corrects these mistaken beliefs and reduces social anxiety.
The human voice uniquely signals a ‘live mind’ (intent, emotion, deliberation) and reliably increases perceived thoughtfulness and cooperation relative to text; use voice when nuance matters.
Brief, everyday social connections (hellos, short conversations, small requests for help) measurably improve mood and health, whereas spending a day alone is strongly associated with worse well‑being and physiological stress.
Our inferences about others’ minds rely on egocentrism, stereotypes, and behavior, each adding accuracy but also predictable errors (e.g., correspondence bias).
Simple, repeatable habits (e.g., a daily “hello walk,” offering sincere compliments) build social connection for oneself and others and can be prescribed like exercise.
Clinical Insight
For patients with social anxiety or loneliness, prescribe real‑world, graded social exposures that target belief updating (e.g., initiating brief, low‑stakes interactions and small help‑seeking). Evidence indicates that miscalibrated expectations—not enduring fear—primarily maintain avoidance; short, authentic interactions (ideally by voice) reliably yield positive feedback that reduces anxiety and improves well‑being.
Actionable Takeaway
Write a ‘Social Exposure’ prescription: once daily for 1 week, initiate one brief in‑person or voice interaction (e.g., greet a stranger, ask someone for a small favor, or offer a sincere compliment); in week 2, add one deeper question (e.g., “How’s your day going?” → “What are you working on today?”). Track mood before/after; prefer voice over text for conversations that require nuance or where disagreement is likely.
46. Huberman Lab
How to Overcome Social Anxiety | Dr. Nick Epley
Published: 2026-05-18
URL: Listen Here
Summary
Evidence converges that small, authentic social exchanges meaningfully improve mental and physical well-being. Social anxiety is best treated with real-world exposure that recalibrates overly pessimistic beliefs about others. Voice and in-person modalities humanize and increase perceived intelligence relative to text, suggesting clinicians and clients should favor voice/in-person touchpoints when feasible.
Key Takeaways
Real-world social exposure—not simulation—reduces social anxiety by updating inaccurate predictions about rejection; people are helped and accepted more often than they expect.
Brief, everyday interactions (greetings, small talk, sincere compliments) reliably lift mood; the biggest well-being gain comes from moving from no contact to some contact.
Voice conveys rich mental-state cues that humanize others; compared with text, speaking increases perceived intelligence and mutual understanding, especially across divides.
We routinely misread others due to cognitive biases (egocentrism, stereotyping, correspondence bias); testing assumptions through low-stakes bids to connect corrects many misinferences.
Short periods of acting more extraverted increase positive affect for most people, including introverts; small, repeated real interactions function as effective ‘social prescriptions’.
Clinical Insight
Loneliness and social isolation are modifiable risk factors linked to increased all-cause mortality, cardiometabolic burden, and dysregulated stress physiology. For social anxiety, graded in vivo exposure is an evidence-based intervention that changes maladaptive social predictions (e.g., overestimating rejection) rather than merely dampening arousal.
Actionable Takeaway
Implement a 2-week graded social exposure plan: daily, initiate one brief, real interaction (e.g., greet a neighbor or cashier, ask a small favor, offer a sincere compliment); log predicted outcome vs. actual outcome to capture expectancy violations. Each week, add 2–3 short voice calls (not texts) to trusted contacts. Progressively increase depth or duration as mispredictions correct.
Stay connected with Dr Onyx MD PhD for clinical insights and wellness tools that bridge science and everyday care:
Instagram ✦ X (Twitter) ✦ LinkedIn ✦ Website
From Insights to Action
Knowledge without execution changes nothing. The insights above only reach their full potential when integrated into a strategic, personalized plan. That’s where two offerings come in:
Personalized Medical AI Chatbot
Healthcare complexity is overwhelming. Clinical studies, conflicting guidelines, and fragmented records leave most patients paralyzed.
Deploy your Dr Onyx MD PhD Medical AI Chatbot—a personalized architecture that synthesizes your medical history, the latest research, and your unique condition into clear, actionable insights.
It’s not a replacement for your doctors—it’s your secret weapon for making better decisions and becoming the CEO of your own care.
👉 Deploy your Medical AI Chatbot today and take control of your health narrative
Premium Longevity Program
For people who know their most valuable asset is their health.
This year-long partnership delivers clarity, accountability, and physician-led execution. Stop collecting fragmented data and start acting on a ranked, strategic plan tailored to your biology and lifestyle.
👉 Discover the Premium Longevity Program and secure your health as your ultimate investment.